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ABSTRACT 
 
Metabolomics is a discipline where metabolites are assessed, identified and quantified in different 
samples. Metabolites are crucial components of the biological system and highly informative 
about its functional state due to the closeness to functional endpoints and to the organism’s 
phenotypes.
 1H  NMR and LC-MS, the commonly used metabolomics analytical platforms  were  
used  to  annotate  the  metabolites  found  in Sclerocarya   birrea   (S. birrea)   leaves  from  
five  South  African  provinces,  Limpopo  (L), Gauteng (G), North West (NW), Mpumalanga 
(M) and KwaZulu-Natal (KZN). Supervised Orthogonal Partial Least Square – Discriminant 
Analysis (OPLS-DA) of the full spectra revealed a clear differentiation of S. birrea leaves from 
five provinces. In addition, the level of common metabolites were measured and compounds 
previously found to have anti-diabetes potential ((-)-epicatechin 3-0-galloyl ester, myricetin-3-0-
α-L-rhamnopyranoside, gallic acid and Kaempferol-3-0-α-L-rhamnopyranoside) were annotated in 
the samples.  The samples from the five provinces showed anti- diabetic activity when exposed to 
an in-vitro glucose uptake assay, with the highest activity observed in male samples from M. The 
sample presented high concentrations of (-)-epicathechin 3-0-galloyl ester, one of the metabolites 
with anti-diabetes activity. Overall 1H NMR and LC-MS metabolic profiling were successfully  
applied  to  discriminate  all  five  sources  of  S. birrea   leaves,  and  obtained qualitative  
information  of  many  common  metabolites.   
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GLOSSARY OF TERMINOLOGIES 
 
 
Antioxidant: Is a molecule that inhibits the oxidation of other molecules. 
 
Data binning: A data pre-processing technique used to reduce the effects of minor 
observation errors. 
 
Diabetes: A disease in which the body is unable to properly use and store glucose (a form of 
sugar).  Glucose builds up in the bloodstream, causing an abnormal increase in blood glucose. 
 
Diabetisane: Natural medicine for high blood sugar. 
 
Glucogenic amino acid: An amino acid that can be converted into glucose through 
gluconeogenesis. 
 
Glycosylation: The enzymatic process that attaches glycan to proteins, lipids or other organic 
molecules. 
 
Hyperglycemic:  A condition in which an excessive amount of glucose circulates in the 
blood plasma. 
 
Hypoglycemic: A condition that involves abnormally diminished contents of the glucose in the 
blood. 
 
In-vitro:  Medical experiments that takes place in test tubes rather than in a living system 
 
Insulin: A hormone produced in the pancreas by the islets of Langerhans, which regulates the 
amount of glucose in the blood. 
 
Mass Spectrometry (MS): An analytical chemistry technique that helps identify the amount 
and  type  of  chemicals  present  in  a  sample  by  measuring  the  mass-to-charge   ratio  and 
abundance of gas-phase ions. 
 
Metabolites: Intermediates and products of metabolism. 
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Metabolism: The set of life sustaining chemical transformations within the cells of living 
organisms. 
 
Metabolome:  The complete set of small molecule metabolites   found within a biological 
sample. 
 
Mtabolomics:  The  systematic  study  of  the  unique  chemical  fingerprints  that  specific 
cellular processes leave behind, the study of their small molecule profiles. 
 
Metformin:   A prescription drug used primarily in the treatment of type II diabetes.  It is 
intended to help control the amount of sugar in the blood, and can be used on its own or 
combined with other medications. 
 
Nuclear Magnetic Resonance (NMR):    A research technique that exploits the magnetic 
properties of certain atomic nuclei. 
 
Pharmacological: The branch of medicine and biology concerned with the study of drug 
action,  where  a  drug  can  be  broadly  defined  as  any  man-made,  natural,  or  endogenous 
molecule which exerts a biochemical and/or physiological effect on the cell, tissue, organ, or 
organism. 
 
Partial least squares discriminant analysis (PLS-DA):  a partial least squares regression of 
a set Y of binary variables describing the categories of a categorical variable on a set X of 
predictor variables. 
 
Principal component analysis (PCA): A statistical procedure that uses an orthogonal 
transformation to convert a set of observations of possibly correlated variables into a set of 
values of linearly uncorrelated variables called principal components. 
 
Secondary metabolites: Organic compounds that are not directly involved in the normal 
growth, development, or reproduction of an organism.
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Theoretical background and world problem 
statement 
 
_ 
 
 
1.1 Introduction 
  
 
Healing has always been a treasure for humankind no matter the race. Recently, there are 
bioprospecting studies initiated to determine medicinal properties particularly from plants. This 
has drawn many scientific studies to rely on traditional medicine accounts. Sclerocarya birrea 
is one of the African traditional trees with reported medicinal values (Mariod and 
Abdelwahab, 2012). The tree  has  been  evaluated  for  antibacterial  potential  (Eloff,  2001),  
hypoglycemic  potential (Ojewole, 2003), antiproliferative  potential (Tonih and Ndip, 2013) 
and many other human aliments (Van Wyk et al., 2000). The use of S. birrea for the 
treatment of various diseases confirms the abundance of medicinal metabolites found in the 
tree. Moreover it was estimated that 25% of the commonly used medicines contain 
compounds isolated from plants (Kumar, 2008).  Amongst  all other  uses  of S. birrea,  the  
tree  is  mostly  used  for  its  anti-diabetes potential. 
 
Diabetes mellitus is a metabolic disorder characterized by a loss of glucose homeostasis with 
conflict  of  carbohydrate,  fat  and  protein  metabolism  resulting  from  defects  in  insulin 
secretion, insulin action or both (WHO, 1999; Pietropopo, 2001; Defronzo, 2004). Without 
enough insulin, body tissues in particular, the liver, muscles and adipose tissues fail to take 
and utilize glucose from the blood circulation. This results in elevated blood glucose levels, a 
condition known as hyperglycemia. If blood glucose levels remains high over a long period 
of time, this can result in long term damage of organs such as kidneys, eyes, nerves, heart 
and blood vessels. Complications in some of these organs can lead to death (Hirch, 1995; 
Brownlee, 2001; Weiss and Sumpio, 2006). 
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An  emerging   field  of  metabolomics   is  aimed   at  uncovering   sites  of  synthesis   and 
accumulation  of structurally diverse compounds  by determining  a metabolome  for a plant 
which  involved  the  profiling  of  the  small  molecules  found  throughout  the  plant  and  in 
response to a variety of growth conditions or treatments (medicinal plant metabolomics 
research). In the current study, NMR analysis combined with LC-MS were used for assessing 
the metabolite contents of methanol extracts of S. birrea leaves and addressed the differences 
in the samples from different geographical regions, this was performed in order to find out if 
the differences in the leaves from different regions affect the plant’s anti-diabetes activity. 
 
1.2 Problem statement 
 
 
Sclerocarya birrea is mostly studied for its anti-diabetic potential. Currently, Type II 
diabetes mellitus, the most common type of diabetes mellitus, is managed by a combination 
of diet, exercise, oral hypoglycemic   drugs and  sometimes   insulin  injections  (Ojewole , 
2003).  However, synthetic oral hypoglycemic drugs, which are currently the main form of 
treatment for Type II diabetes mellitus have shown to have detrimental side effects and 
high secondary failure rates (Baily, 2000; Erasto et al., 2005; Dey et al., 2007). 
 
In addition, these drugs are not affordable to the majority of people living in the rural 
communities of the developing countries such as South Africa because of their high cost 
(Baily, 2000). These limitations, of currently available anti-diabetic pharmacological agents 
have motivated researchers   all over the world to investigate alternative   anti-diabetic remedies.  
In particular,  consideration  was  given  to  plants  and  herbs  used  by  traditional healers and 
herbalists as anti-diabetic remedies with the hope of discovering new natural products that can 
be used or developed into safe, inexpensive and effective anti-diabetic remedies. 
 
Numerous studies have established that the stem bark extract of S. birrea subspecies caffra 
possess anti-diabetic effects (Ojewole, 2003) but removing the stem bark can be detrimental 
to the plant. Furthermore, an in-vitro cell culture based assay (results unpublished) carried 
out recently at the Medical research council (MRC) in collaboration with the University of 
KwaZulu-Natal (UKZN), S. birrea leaf extract (a sustainable source) showed activity against 
Type II diabetes. In order to further study these properties in patients a significant quantity of 
S. birrea leaves will be required.  Further, should these studies confirm the activity of S.
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birrea against Type II diabetes in patients, a sustainable source of S. birrea  leaves will be 
required most likely from different regions of South Africa. For this reason, it is important to 
determine whether there are any differences in secondary metabolites in plants from different 
provinces. In this study the effect of geographical distribution of S. birrea was investigated 
and this was linked to the in-vitro anti-diabetes activity of the plant. 
 
1.3   Aim, research question and objectives 
 
1.3.1 Aim 
 
 
The Aim of the study was to investigate whether S. birrea from selected South African 
regions have identifiable differences in chemical composition which can affect the plant’s 
anti-diabetic activities. 
 
1.3.2 Research questions 
 
 
 Does S . birrea   from different regions differ in chemical composition and in 
medicinal properties? 
 Are there any identifiable   components   responsible   for differences   between 
samples? 
 How do the differences in chemical composition of the samples affect the in-vitro 
 
                 uptake of glucose by C2C12 cells. 
 
 
1.3.3 Objectives 
 
 
 Perform NMR and MS analysis on the crude extract 
 
 Conduct metabolomics analysis to identify the differences between the samples. 
 
 Use metabolomics to construct the chemical profile of compounds. 
 
 To compare the degree of glucose uptake by aqueous extracts of S. birrea f ro m 
five different provinces. 
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1.4 Overview of the dissertation 
 
Chapter 1 of this dissertation describes the general introduction of the study.  This was then 
followed by the world problem statement, research questions and Aims. Chapter 2 begins with 
an overview on an introduction to metabolomics in medicinal plants and the analytical 
techniques used in metabolomics search. This was then followed by the description of 
Sclerocarya birrea, and its medicinal values. Chapters 3 and 4 we combined qualitative 
approach to investigate the differences in Sclerocarya birrea from different provinces and the 
metabolites responsible for the differences. Chapter 5 present the in-vitro glucose uptake of 
Sclerocarya birrea leaves from different provinces. The final chapters 6 and 7 deals with the 
general discussion and conclusion of the study. 
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2 Literature review 
 
 
 
 
2.1 Introduction and aim of the literature review 
 
Several analytical techniques have been developed in the characterization of plant materials. These 
techniques allow the detection of bio-activities from natural products, especially medicinal plants. 
Nuclear Magnetic Resonance (NMR), one of the techniques used in metabolomics, has the 
potential to provide evidence for the existence of clear Metabolomic differences among samples 
according to their places of origin. There has been a wide interest in the medicinal uses of S. 
birrea for centuries; this was advantaged by its potential to treat diseases (Street and Prinsloo, 
2012). The tree has already demonstrated to present hypoglycemic effect and can therefore be 
used in the management of Type II diabetes mellitus (Ojewole, 2003). The aim of this literature 
review is to establish the current status of knowledge regarding different metabolites found in S. 
birrea a n d  how they influence the plant’s medicinal values, in particular, consideration given 
to the treatment and management of Type II diabetes mellitus. 
 
2.2 Introductions to metabolomics in medicinal plant 
 
Natural products from plants serve as rich resources for drug development.  Plant derived 
natural products have had a profound and a lasting impact on human health and includes 
compounds successfully used for decades such as digitalis, vincristine, taxol and morphine 
isolated from foxglove, periwinkle, yew, and opium poppy, respectively (Gurib-Fakim, 
2006).The structural diversity and biological activity of plant-derived compounds suggest that 
additional, medicinally relevant compounds remain to be discovered in plants (Hur et al.,2013)
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Providing the metabolome for medicinally relevant plant species is one means to reveal a 
deeper understanding of the metabolic potential of plants, and thus provide the opportunity to 
uncover sites of synthesis and accumulation of structurally diverse compounds (Wurtele et al., 
2012). Determining the metabolome for a plant involves the profiling of small molecules found 
throughout the plant in all the tissues and organs, and in response to a variety of growth 
conditions and treatments (Hur et al., 2013).  No single analytical method is sufficient to 
observe all the chemical diversity within the plant. In metabolomics studies, metabolic profiles are 
surveyed doing comprehensive measurements using mass spectrometry (MS) or Nuclear 
Magnetic Resonance (NMR) spectroscopy (Jantan,2004). Studying a whole metabolic profile 
instead of only a few molecules provides a more  comprehensive  view  of  the  complexity  of  
the  underlying  biochemical  processes (Van Der Greef et al., 2011).  Metabolomics studies have 
the potential to provide in-depth answers to biological questions.  
 
2.2.1 Analytical technologies commonly used in metabolomics research 
 
Mass Spectrometry (MS) 
MS  has  been  extensively  developed  in  the  past  few  decades  and  holds  a  distinguished 
position in qualification and separation science (Dettmer et al., 2007). Recent advances in MS 
based metabolomics have created the potential to measure the levels of hundreds of metabolites 
that are  the  end  products  of  cellular  regulatory  processes  (Griffin  et  al.,  2010).  Due to its 
high sensitivity and wide range of covered metabolites, MS has become the technique of choice in 
many metabolomics studies (Griffin et al., 2010). The aims of developing MS for 
metabolomics range from understanding the structural characterization of important   metabolites 
to biomarker discovery (Zhang, 2012). MS can be used to analyze biological samples either by 
direct-injection or following chromatographic separation   (Griffin   et   al.,   2010).  Recent 
developments and improvements in mass accuracy have dramatically expanded the range of 
metabolites that can be analyzed by MS and have improved the accuracy of compound 
identification (Domon 2010).  
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Nuclear Magnetic Resonance spectroscopy (NMR) 
 
In the past decade, metabolomics has been developed as an important field of plant sciences 
and natural products chemistry (Krishnan et al., 2004). The ultimate goal of metabolomics is 
to measure all the metabolites in an organism both qualitatively and quantitatively, which can 
provide a clear metabolic picture of a living organism under certain conditions, this is a very 
ambitious goal, as the plant metabolome is very complex (Kim et al., 2010). This makes the 
analysis of all metabolites in one single experiment extremely difficult. In view of this, instead of 
aiming to analyze all individual metabolites quantitatively and qualitatively, a more realistic and 
suitable approach will be to have a general view of all the metabolites present in an organism 
under certain conditions. NMR is a very suitable method to carry out such an analysis because it 
allows the simultaneous detection of diverse groups of secondary  metabolites  (flavonoids,  
alkaloids,  terpenoids)  besides  abundant primary metabolites (sugars, organic acids and amino 
acids) ( Doughari, 2012). NMR is a very useful technique for structure elucidation. Using various 
two-dimensional NMR measurements, many signals can be identified often without the need for 
further fractionation of the extract (Krishnan et al., 2005). 
 
2.2.2 Experimental Procedures for NMR in metabolomics 
 
Metabolomics is focused on the complete analysis of all metabolites of a certain sample. A major 
problem resides in the challenge to obtain a sample which permits the complete analysis of all 
metabolites contained in it, which is virtually impossible. If this sample is treated in some way, 
by extraction, separation or derivatisation, information will be lost (Kim et al., 2010). In an 
extraction only the soluble components are obtained and insoluble or partly soluble compounds 
are lost. When a separation is performed, certain parts of the sample are also lost. 
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2.3 Sample preparation for metabolomics research 
 
In metabolomic studies, it is important that the reproducibility of the procedure is as best as 
possible (Defernez and Colquhoun, 2003).  All sources of variation should be minimized. When 
leaves from a plant are collected, the position of the leaf, its age, exposure to sunlight and rain 
as well as the time of collection and the weather should be considered,  all these factors 
potentially causes variation (Maher et al., 2007). After collection the sample treatment is 
important such as storage (room temperature or frozen) processing of the sample, artifacts might 
arise from interaction with solvents or by residual enzymatic activity (Kim et al., 2010). To 
analyze the metabolome as completely as reasonably possible,  a  single  solvent  will  not  be  
sufficient  (Verpoorte  et  al.,  2007).  A reasonable coverage of all metabolites can be obtained 
with two solvents: one apolar extract (e.g. with chloroform) and a polar extract (e.g. with water or 
water–methanol) (Verpoorte et al., 2007). A problem with water extracts is often the high 
quantity of sugars (Schripsema, 2010). Lipids are generally the major components of the extract, 
when there are problems with superimposed signals, better results might be obtained by the use 
of two-dimensional NMR, e.g. J-resolved NMR (Viant, 2003; Liang et al., 2006; Widarto et al., 
2006), TOCSY or HMBC (Widarto et al., 2006), or further fractionation of the samples should be 
undertaken. 
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Protein depletion of samples is generally not considered to be essential, but it should be considered  
that  in  water  extracts,  the  catalytically  active  proteins  might  interfere  in  the spectrum 
(Schripsema, 2010). For example, sucrose in papaya extracts is rapidly converted by invertase 
activity into glucose and fructose (Schripsema et al., 2009).  For serum samples a  number of 
deproteinisation procedures were investigated by Daykin et al. (2002) and later by Tiziani et al. 
(2008). They found that the best results were achieved by ultrafiltration, which removes proteins 
quantitatively, yields good signal-to-noise, and is superior in reproducibility (Kim et al., 2008). If 
in the sample preparation procedure the sample is dried and re-dissolved in a  deuterated  solvent,  
volatile  components  should  be  completely  or  partially  lost,  e.g. ethanol (Tiziani et al., 2008) 
or salicylic acid (Kim et al., 2008). For extraction of biological material a suitable solvent 
mixture from the many available options should be selected. For this selection a number of 
parameters are considered (Kim et al., 2008): 
 
1.   The  solvent  strength  of  solvents  as  indicated  in  Table  2.1  gives  a  reasonable 
impression of the type of compounds which might be extracted. However, acid/base 
behavior should also be considered (Kim et al., 2008). 
 
2.   Boiling point is important if solvents need to be evaporated, which might lead to 
thermal decomposition or loss of compounds by evaporation (Kim et al., 2008). Water 
as a solvent, despite the relatively high boiling point, has the advantage that it can 
easily be removed by lyophilisation (Kim et al., 2008). 
 
3.   Toxicity and environmental considerations—for example, benzene should be avoided 
due to its carcinogenicity and can in extractions easily be substituted with toluene 
(Kim et al., 2008). 
 
4.  Possible contaminations in solvents that may interfere with the analysis, yielding 
unwanted signals in the spectrum, (Kim et al., 2008). 
 
5.   Possible contaminations that may cause artifact formation, e.g. peroxides (in ethers) 
and dichlorocarbene (in chloroform) (Kim et al., 2008) 
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Table 2.1: A series of solvents listed according to their eluting power on alumina 
adsorbent. The empirical solvent strength data were reported by Snyder (1968). 
 
 
Solvent Solvent strength 
Water 
Methanol 
Ethanol 
2-Propano 
Dimethyl sulfoxide 
Pyridine 
Acetonitrile 
Ethyl acetate 
Tetrahydrofuran 
Acetone 
Dichloromethane 
Chloroform 
Diethyl ether 
>>1 
 
0.95 
 
0.88 
 
0.82 
 
0.75 
 
0.71 
 
0.65 
 
0.58 
 
0.57 
 
0.56 
 
0.42 
 
0.40 
 
0.38 
 
2.4 NMR measurement 
 
After preparation of the samples they should be submitted to NMR. Liquid samples in non- 
deuterated solvents can be submitted to NMR, but in that case a little deuterated solvent 
should be added to provide the lock signal for NMR and during the measurement, and solvent 
suppression should be applied (Ottiger and Bax, 1999). When the samples are dry they should be 
dissolved in deuterated solvents. The commonly available deuterated solvents are D2O, methanol-
D4, DMSO-D6, acetone-D6, chloroform-D and benzene-D6 (Hatada and Kitayama, 2004). The 
choice of solvent is determined by the nature of the sample and its preparation,  for polar extracts 
usually D2O, methanol-D4 or a mixture of the two is used, with chloroform used for apolar 
extracts (Schripsema, 2010). Special  care  should  be  taken  with  the  apparatus  adjustments,  
such  as  shimming  and temperature. Moreover, during processing care should be taken with the 
phasing, line broadening and zero filling (Defernez and Colquhoun, 2003).  
13 
 
 
 
 
 
 
 
2.5 Data processing 
 
After the NMR spectra have been obtained, they should be processed to extract the data (Johnson 
and Blevins, 1994). Three methods to extract the data are: binning, peak-picking or deconvolution 
(Scalbert et al., 2009). One of these techniques is necessary, because the crude NMR data show 
artefacts due to physicochemical differences (Torgrip et al., 2008). Forshed et al. (2005) 
investigated two dedicated peak alignment methods and found that both produced better results 
than the bucketing approach. The best approach, however, is the deconvolution of the NMR 
spectra into the individual compound spectra, this approach has been described by Weljie et al. 
(2006) and the name ‘targeted profiling’ was proposed.  
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2.6 Sclerocarya birrea 
 
2.6.1 Classification and description 
 
Sclerocarya birrea, (A. Rich) Hochst, subspecies caffra (sond) kokwaro popularly known as the 
“cidar tree” or marula (English), maroela (Afrikaans), umgamu (Zulu) belongs to the plant family 
Anarcardiaceae,  which encompasses 73 genera and about 600 plant species (Pretorius et al.,1985; 
van Wyk et al., 1997). Sclerocarya birrea is a medium sized, single stemmed, terrestrial, erect, 
perennial deciduous tree of about 10-15m in height (van Wyk et al., 1997). The stem bark of marula 
tree is flaky, with a grey mottled appearance due to contrasting gray and pale-brown pattern. The 
leaves are compound, about 10 cm long, with a varying number of pairs of ovate leaflets, but always 
one terminal leaflet. Only the female trees bear fruit while the male trees displays flowers (Figure 
2.1A). The flowers are borne on small oblong clusters and are small with red sepals and yellow 
petals (Ojewole, 2003). Female S. birrea trees bear plum-like stony fruit (figure 2.1B) of about 
30mm in diameter. The fruits are pale yellow when ripe (Figure 2.6C) (from late South African 
summer to mid-winter), fleshy and contain one kernel with 2 to 4 seeds (van Wyk, et al., 2000;  
Ojewole, 2003). 
  
 A                                                                  B                                                         C 
 
 
 
Figure 2.1: Structure of the male and female S. birrea flowers: left = male and right= female; (b) 
Structure of a S. birrea unripe fruits; (c) Structure of a S. birrea ripe fruit, (Van wyk et al., 2000). 
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2.6.2 Distribution and habitat 
 
Sclerocarya birrea is widespread in Africa, from Ethiopia in the North to KwaZulu-Natal (South 
Africa) in the south, from Gambia in the west across to Nigeria and Cameroon in Central Africa, and to  
Kenya  and  Sudan  in  the  East  (van  Wyk  et  al.,  2000;  Belemtougri  et  al.,  2007).  Its distribution 
in Africa is believed to have followed the Bantu people in their migrations, as it has been an 
important  item  in their  diet  since  time  immemorial  (Van  wyk  et  al.,  2000). Sclerocarya birrea 
grows naturally in various types of woodlands on sandy soil or occasionally on sandy loam soils (van 
Wyk et al., 2000). 
 
2.6.3 Phytochemical studies of Sclerocarya birrea 
 
The ripe fruit of S. birrea is reported to have a high content of vitamin C (168 mg/100g), which is 
approximately three times higher than that of oranges and comparable to the amount found in guava 
(Wilson, 1980; Eromosele, 1991). According to Ogbobe, (1992) and Smith et al., (1996), the nuts 
found in the fruit of S. birrea contain crude oil (11.0%), carbohydrate (17.2%), crude protein 
(36.7%), fibre (3.4%) and crude saponinis (0.9%), minerals as well ascorbic acid. The gum from the 
tree is rich in tannin, and sometimes used in making an ink substitute (Venter and Venter, 1996). 
 
Furthermore, Watt and Breyer-Brandwijk, (1962) and Dimo et al., (2007) found that both the stem bark 
and the leaf extracts of S. birrea contain alkaloids, flavonoids, tannins and saponosides.  A condensed 
tannin, (-)-epicatechin-3-galloyl ester extracted from the stem bark of S. birrea has been shown to have 
insulin secretagogue activity (Galvez et al., 1992). In addition, Ojewole (2003) has discussed the 
possibility that arginine, glutamic acid, coumarins and/or terpenoids which are contained in the aqueous 
stem bark extract of S. birrea could be responsible for the hypoglycemic effect. 
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2.6.4 Pharmacological uses of Sclerocarya birrea 
 
 
In South Africa and some African countries the stem-bark, roots and leaves of S. birrea  are 
traditionally used in folk medicines for the treatment, management and control of a variety of human  
ailments,  including  malaria,  diarrhea,  hypertension  and  diabetes (Van  wyk  et  al., 2000). The folk 
use of S. birrea  for medicinal purposes have been supported by studies which have shown that stem-
bark and leaf extract of S. birrea  possess a number of pharmacological activities, including 
analgesic, anti-inflammatory, anti-diabetic and hypoglycemic (Ojewole, 2004; Dimo et al., 2007), 
antidiarrheal (Galvez et al., 1991; 1993) and antibacterial activity (Eloff, 2001). 
 
2.6.5 Hypoglycemic and anti-diabetic research of Sclerocarya birrea 
 
Type II diabetes affect many metabolic pathways in different tissues, many of which potential targets 
for drug treatment (Van de Venter et al., 2013). Unfortunately, this complicates the identification of 
new treatments, as most in-vitro screening models consider single cell type, metabolic pathway or 
enzyme, thus reducing the possibility to identify an anti-diabetic compound (Van de Venter et al., 
2013). Type II diabetes is characterized by hepatic and peripheral (muscle, adipose tissue) insulin 
resistance (Van de Venter et al., 2013). The pancreas compensate by secreting more insulin (Figure 
2.2), but eventually the beta cells will fail to sustain this (Cerasi, 2000), at which stage the 
patient  requires insulin treatment  (Van de Venter et al., 2013). During the time when insulin is 
still produced, various other drugs in combination with alteration in life style can be used to manage 
the disease (Matthaei et al., 2000). These drugs work through a number of different ways to 
reduce blood glucose level (Cheng and Funtus, 2005) (Figure 2.3).  In this study S. birrea was 
selected based on literature reports for its anti-diabetic activity. 
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Figure 2.2: The role of the pancrease in glucose homeostasis (Cheng and Fantus,2005). 
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Figure 2.3: Major target organs and actions of orally administered anti-hyperglycemic  
agents in Type II diabetes  mellitus. TZD=thiazolidimedione; FFA= free fatty acid; AGI= 
glucosidase inhibitor (Cheng and Funtus,  2005). 
 
 
The blood lowering effect of S. birrea stem-bark extract has been studied and confirmed using 
experimental animal models of diabetes. Recent studies have shown that administration of 300 
mg/kg stem-bark methanol/methylene chloride extract of S. birrea exhibited at termination, a 
significant reduction in blood glucose, increased plasma insulin levels, and reduced plasma 
cholesterol, triglyceride and urea levels (Dimo et al., 2007). 
 
2.7 Secondary herbal metabolites with reported medicinal properties 
 
The medicinal  and  pharmacological  actions  of  medicinal  herbs  are  often  dependent  on the 
presence of bioactive compounds called secondary herbal metabolites (Bruneton, 1999; Henrichet  
al., 2004). Unlike the ever-present macromolecules of primary metabolism (e.g. monosaccharides, 
polysaccharides, amino acids, proteins, nucleic acids and lipids) which are present in all plants, 
secondary metabolites with medicinal properties are found only in a few species of plants (Henrich 
et al., 2004).  Some of these secondary metabolites serve as defensive compounds against herbivores 
and pathogens.  Others  function  in  mechanical    support,  in  attracting  pollinators  and  fruit  
dispersers,   in  absorbing  harmful  ultraviolet radiation, or reducing the growth of nearby 
competing plants (Cheynier, 2005; Gurib-Fakim, 2005).   Secondary  herbal   metabolites   with  
reported   medicinal   properties   in  particular anti-diabetes properties include, alkaloids, 
flavonoids, tannins and saponosides ( Dimo et al.,2007). These metabolites are briefly discussed 
below. 
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2.7.1 Alkaloids 
 
Alkaloids often contain one or more rings of carbon atoms, usually with a nitrogen atom in the 
ring. Many have declared pharmacological activity (Harborne, 1998). Most alkaloids have a strong 
bitter taste and are very toxic, for these reasons they are used by plants to protect themselves 
against herbivory, and attacks by microbial pathogens and invertebrate pests (Harborne, 1998). 
Several alkaloid containing medicinal herbs are reported to have been used by the early man as pain 
relievers, as recreational stimulants or in religious ceremonies to enter a psychological state to 
achieve communication with ancestors or God (Heinrich et al.,2004; Gurib-Fakin, 2005). Alkaloids 
are classified into several groups either on the basis of their basic ring system (e.g. atropine, indole, 
quinoline, isoquinoline, imidazole, piperidine alkaloids), plant sources (e.g. opium, belladonna, vinca, 
cinchona and ergot alkaloids) or their pharmacological properties  (e.g. analgesic,  stimulant  or anti-
malarial  alkaloids)  (Kinghorn and  Balandrin,  1993;  Bruneton,  1999,  Harborne,  1998;  Henrich  et  
al., 2004).   
 
2.7.2 Phenolics 
 
Phenolics is a class of herbal secondary metabolites that are characterized by the presence of one or 
more hydroxyl (-OH) groups attached to a benzene ring or to other complex aromatic ring structures 
(Bruneton, 1999, Harborne, 1998 and Henrich et al., 2004). Phenolic herb secondary   metabolites   are  
widely  distributed   in  herbs  and  are  responsible   for  color development,  pollination  and  
protection  against  UV  radiation  and  pathogens  (Bruneton, 1999; Henrich et al., 2004). They also 
contribute to the color and astringency of some foods. On the basis of their structure, phenolic 
compounds can be classified into two broad classes: the non-flavonoids and the flavonoid phenolic 
compounds (Bruneton, 1999; Henrich et al., 2004). 
 
2.7.2.1 Non-flavonoid phenolic compounds 
 
Non-flavonoid  phenolic  compounds  include  simple  phenols  (eugenol,  catechol, hydroquinone,  
phloroglucinol  hydroquinone,  and p-anisaldehyde)  (Jadhav et al., 2004), the C6-C1 benzoic acids 
(vanillic acid, gallic acid and protocatechuic acid), the C6-C3 phenyl propanoids  and  their  
derivatives  (cinnamic  acid,  caffeic  acid,  ferulic  acid  myristicin  and sinapyl alcohol), coumarins 
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(scopoletin; warfarin and dicoumarol), hydrozable tannis (gallotannins and ellagitannins) and lignans 
and related compounds (Kumar et al., 2010). 
 
2.7.2.2 Flavonoid phenolic compounds 
 
Flavonoids are a large and complex group of compounds containing a three ring structure with 
two aromatic centers and a central oxygenated heterocyclic ring (Bohm, 1998; Hollman and Katan, 
1999). The six major classes of flavonoids are flavones, flavonols, flavonones, catechins  (flavanols)  
anthocyanidins  and isoflavones  (Bohm,  1998; Bruneton,  1999; Pieta, 2000;  Scalbert  et  al.,  
2005;  Goutam  and  Dilip,  2006).  Flavonoids  have  several  proven medicinal properties,  such as 
anti-inflammatory,  anti-oxidant,  anti-cancer,  antibacterial and antiviral properties  (Hollman and 
Katan, 1999; Harborne and Williams, 2001; Cheynier, 2005; Manach et al., 2004). 
 
2.7.3 Glycosides 
 
Glycosides are secondary metabolites made up of two components, a carbohydrate component 
known as the glycone and a non-carbohydrate component known as the aglycone. The glycone 
component usually consists of one or more glucose units whereas the aglycone may be any 
one of the secondary metabolites discussed above (Bruneton, 1999; Heirich et al., 2004; 
Gurib-Fakim, 2005). Aglycones tend to be soluble in organic solvents and sugar part in 
aqueous solvents. In general, glycosides can be extracted with acetone, ethanol or an 
aqueous/ethanol mixture   (Jones   and   Kinghorn,   2005).   Medicinally   important   glycosides   
consist   of anthraquinone glycosides, coumarin glycosides and steroidal (cardiac) glycosides. 
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 2.7.3.1 Anthraquinone glycoside 
 
Herbs such as Cassia senna, rhubarb (Rheum palmentum), cascara (Rhamnus purshiana)  and Aloe 
vera have long been known for their laxative properties (Bruneton, 1999; Heinrich et al., 2004; 
Gurib-Fakim, 2005). This property has been attributed to the presence of anthraquinone and 
enthrones glycosides present in these plants (Heinrich et al., 2004). When ingested anthraquinone  
glycosides  hydrolyze  in the large intestine (colon) to liberate the aglycones which stimulate 
peristalsis and increase water retention in the colon (Bruneton, 1999). 
 
2.7.3.2 Coumarin glycosides 
 
Coumarins  glycosides  are  phytoalexins,  and  are  synthesized  by the  plant  in  response  to 
bacterial  or  fungal  infection,  physical  damage,  chemical  injury,  or  a  pathogenic  process 
(Gurib-Fakim,   2005).  For example, scopoletin is synthesized by the potato (Solanum tuberosum) 
following fungal infection. Coumarin glycosides are very fragrant. They are the source,  for  
instance,  of  freshly-mown  hay  scents  (Heinrich  et  al.,  2004).  Medicinally, coumarin 
glycosides have been shown to have hemorrhagic,  anti-fungicidal,  and antitumor activities 
(Bruneton, 1999). 
 
2.7.3.3 Steroidal glycosides 
 
Steroidal (cardiac) glycosides are naturally occurring drugs whose actions include both beneficial  
and toxic effects  (at higher doses) on the heart  (Bruneton,  1999; Gurib-Fakim, 2005; Heinrich 
et al., 2004). Herbs containing cardiac glycosides include Digitalis purpurea (foxglove) and 
Strophanthus.  Foxglove is the source of two potent glycosides used as heart stimulants; digoxin 
and digitoxin. Both digoxin and digitoxin are widely used in the modern treatment  of congestive  
heart  failure,  atrial  fibrillation  and  flutter  (Heinrich  et al., 2004).. 
 
2.8 Selection of herbal species 
 
Any plant species and herb part collected randomly can be investigated using available 
phytochemical methods. However, a more targeted approach is often preferred to a random 
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selection (Kinghorn and Balandrin, 1993; Harborne, 1998). Extracts prepared from herbs used as 
traditional remedies to treat certain diseases are more likely to contain biologically active 
compounds of medicinal interest (Yuan and Lin, 2000). Literature early in the selection process can 
provide some preliminary information on the type of natural products already isolated from the plant 
and the extraction methods employed to isolate those (Heinrich et al., 2004). Another approach 
known as the information driven approach, utilizes a combination of ethnobotanical, 
chemotaxonomic and random  approaches   together with  a  data  base  that  contains   all  relevant   
information concerning  a  particular  plant  species  (Kinghorn  and  Balandrin,  1993;  Harborne,  
1998). The database is used to prioritize which herbs should be extracted and screened for biological 
activity.  
 
2.8.1 Collection and identification of plant material 
 
The whole plant or a particular part can be collected depending on where the metabolites of interest 
(if they are known) accumulate. Hence aerial (e.g. leaves stems, flowering tops, fruit, seed, and bark) 
and underground (e.g. tubers, bulbs, roots) parts can be collected separately. Collection of herb 
materials can be influenced by factors such as the age of the plant and environmental conditions 
(e.g. temperature, rainfall, amount of daylight, soil characteristics and altitude) (Williams et al., 
1996; Harborne, 1998). Thus, it is important to take this into consideration for the re-collection 
purpose, in order to ensure a reproducible profile (nature and amount) of metabolites (Satyajit et 
al., 2006).  The plant from which the material is collected must also be identified correctly.  A  plant  
taxonomist  or  a  botanist  should  be involved  in the detailed authentication  of the plant (i.e. 
classification  into its class, order, family, genus and species) (Satyajit et al., 2006). Any feature 
related to the collection, such as the name of the plant, the identity of the parts collected, the 
place and date of collection, should be recorded as part of the voucher deposited in a herbarium for 
future reference (Harborne, 1998; Satyajit et al., 2006). 
 
2.8.2 Extraction of plant materials 
 
Herbal materials are commonly extracted by means of liquid solvents in what is known as the 
“solid-liquid solvent extraction” (Starmans and Nijhuis, 1996).  Typical solid-liquid solvent 
extraction processes for herbal materials involve drying and grinding of the herbal material, choosing 
a suitable extraction solvent and extraction procedure (Starmans and Nijhuis, 1996; Cheng et al., 
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2001; Jones and Kinghorn, 2005). 
 
2.8.3 Drying and grinding the plant material 
 
Once the herbal material has been collected, it needs to be dried as soon as possible.  A 
common practice is to leave the sample to dry on trays at ambient temperature and in a room with 
adequate ventilation (Heinrich et al., 2004; Satyajit et al., 2006). Dry conditions are essential to 
prevent microbial fermentation and subsequent degradation of metabolites.Herbal materials should be 
sliced into small pieces and distributed evenly to facilitate homogeneous drying.  Protection from 
direct sunlight is advised to minimize chemical reactions induced by ultraviolet rays (Satyajit et 
al., 2006). To facilitate the drying process, the material can be dried in an oven. This can also 
minimize reactions  (e.g. hydrolysis  of glycosides)  that  can occur as long  as there  is some  
residual moisture  present  in  the  herbal  material.  The dried material should be stored in sealed 
containers in a dry and cool place. Storage for prolonged periods should be avoided as some 
constituents may be decomposed (Heinrich et al., 2004; Jones and Kinghorn, 2005). After 
drying, herbal materials are commonly grounded into a fine powder (Figure 2.4). Grinding of plant 
materials into smaller particles facilitates subsequent extraction procedures by rendering the sample 
more homogeneous, increasing the surface area, and facilitating the penetration of solvents into cells 
(Harborne, 1998; Sat yajit et al., 2006). Mechanical grinders (e.g. hammer and  cutting  mills)  are  
employed  to  shred  the  herbal  material  into  various  particle  sizes.  
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Figure 2.4: Grinding of S. birrea leaves on a cutting mill 
 
 
2.8.4 Choice of a suitable extraction solvent 
 
The choice of the extraction solvent depends mainly on the polarity and hence the solubility of the 
bioactive compounds of interest.  Although water is usually applied as a solvent in many 
traditional protocols, organic solvents of varying polarities are often used (either alone or in 
different combinations) in modern methods of extraction to exploit the solubility of herbal 
ingredients (Lapornik et al., 2005). The polarity and chemical profiles of most of the common 
extraction solvents have been determined (Ayaffor et al., 1994; Eloff, 2001; Cowan, 1995) and are 
summarized in table 2.2. 
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Table 2.2: Polarity and chemical profiles of most of the common extraction solvents 
 
 
Polarity Solvent Extracted chemical  profile Reference 
Low Chloroform Fatty acids, waxes and terpenoids Perett et al., (1995) 
 
Cowan, (1999) 
Bruneton, (1999 
Medium Acetone Less polar and polar flavonoids, 
 
tannins, terpenoids 
and glycosides 
Eloff, (1998) 
 
Bruneton, (1999) 
Scalbert et al., 2005 
High Methanol 
 
 
 
 
 
 
 
 
 
 
Ethanol 
 
 
 
 
 
 
 
Aqueous acid 
or base 
Carbohydrates, lecitin, amino acids, 
polypeptides,  
phenolic acids, phenylpropanoids, polar 
flavonoids, 
glycosides and alkaloids 
 
 
 
Polar flavonoids, tannins and glycosides 
 
(saponins) 
 
 
 
 
 
 
 
Alkaloid 
Bruneton, (1999) 
Scalbert et al., 2005 
 
 
 
 
 
 
 
 
Cowan, (1999) 
Bruneton, (1999) 
 
 
 
 
Bruneton, (1999) 
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Thus, if the polarity or the solubility of the compounds of interest is known, t h e  information in 
the above table can be used to select a proper extractor solvent or a mixture of two or more 
solvents of different polarity (Kaul et al., 1985). Alternatively, a solvent such as acetone, which has 
the capacity to extract both polar and non-polar substances, and has been recommended  by Eloff  
(2001)  for  the  extraction  of  most  polar  and  nonpolar  compounds can be used.  If the polarity 
of the compounds of interest is not known, the powdered herbal material can be extracted 
simultaneously with a mixture of different proportions of two or more solvents of different 
polarity (Bruneton, 1999, Cowan, 1995). Alternatively, the powdered herbal material can be 
extracted sequentially with solvents of different polarity in what is known as a sequential 
extraction procedure (Bruneton, 1999). 
 
2.8.5 Choice of the extraction procedure 
 
The choice of the extraction procedure depends on the nature of the source material and the 
compound to be isolated. Solvent extract procedures applied to herbal products include but are 
not limited to maceration, percolation, soxhlet extraction, steam distillation and sequential solvent 
extraction ( 1998; Jones and Kinghorn, 2005). 
 
2.8.5.1. Maceration 
 
This simple, but still widely used procedure involves leaving the pulverized plant to soak in a 
suitable solvent in a closed container at room temperature (Harborne, 1998). Occasional or 
constant stirring of the preparation (using mechanical shakers or mixers) can increase the speed 
of the extraction. Maceration involves soaking the herbal material in a suitable solvent, filt ering 
and concentrating the extract (Harborne, 1998; Jones and Kinghorn, 2005). The use of a cold 
solvent reduces decomposit ion, but the process takes longer and uses larger amounts of solvent. 
  
2.8.5.2. Percolation 
 
This is  similar  to the  maceration  process,  but  hot  solvent  is refluxed  through  the herbal 
material. It is q uicker and uses less solvent, but decomposition due to heat may occur (Jones and 
Kinghorn, 2005; Satyajit et al., 2006). 
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2.8.5.3. Soxhlet extraction 
Soxhlet extraction is a form of continuous percolation with fresh solvent, which uses special glass 
ware. In this procedure, the herbal material is separated from the extract by encasing it in a 
paper cap beneath the dropping condensed solvent.  When full, the solvent in the thimble 
siphons off into the main vessel containing the extractant, and the process continues (Jones and 
Kinghorn, 2005). The advantage of this procedure is that fresh solvent continually extract the 
herbal material  more effectively  with  minimum  solvent,  however,  heating  and hence 
decomposition of compounds is again a disadvantage (Nikhal  et al.,2010). 
 
2.8.5.4. Steam distillation 
 
There is a special apparatus for distilling volatile oils which are immiscible with water. If 
compounds  being  extracted  are water  soluble,  the  method  is  less  useful  because  a  large 
volume of aqueous extract is produced. However, in some cases a partition system may be used 
to concentrate the extract (Jones and Kinghorn, 2005; Satyajit et al., 2006). 
 
2.8.5.5. Sequential solvent extraction 
 
If the polarity y and solubility of compounds that are isolated is not known, a convenient and 
frequently used procedure is sequential solvent extraction. In sequential solvent extraction, the 
herbal material is extracted with a series of solvents of different polarity (Starmans and Nijhuis, 
1996). The usual way is to start with a non-polar solvent and exhaustively extract the herbal 
material followed by a series of more polar solvents until several extracts are obtained of 
increasing solute polarity. For example, a first step, with dichloromethane, will extract terpenoids,  
less  polar  flavonoids  (flavones,  flavonols,  flavonones)  and  other  less  polar materials (Jones 
and Kinghorn, 2005, Okwu, 2001). A subsequent step with acetone or ethyl acetate will extract 
flavonoid glycosides and other medium polar constituents. A subsequent extraction  with  an  
alcohol  or  water  will  extract  highly  polar  constituents  (Jones  and Kinghorn,  2005).  Once  
the  extraction  is complete,  the  extractant  is usually  concentrated under  vacuum,  for  large  
volumes  of  solvents  and  blown  down  under  nitrogen  for  small volumes, ensuring at the same 
time that volatiles are not lost. Aqueous extracts are generally freeze-dried  and  stored  at  -20ºC  
as  this  low  temperature  reduces  the  degradation  of  the bioactive natural products (Starmans 
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and Nijhuis, 1996). Extraction protocols may sometimes be modified depending on the type of 
mole cules being extracted, for example, acids may be added to extract alkaloids as their salts 
(Jones and Kinghorn, 2005). 
2.8.6 Bioassay guided fractionation and isolation of active compounds 
 
Active fractions are fractionated using bioassay guided fractionation. In bioassay-guided 
fractionation, a crude mixture is fractionated into its fraction components using chromatographic 
procedures, followed by biological evaluation (bioassay) of each fraction (Vaidya and Antarkar, 
1994). Only fractions which display biological activity in the bioassay are selected for further 
fractionation. The cycle of fractionation and testing and further fractionation is repeated until a pure 
compound with the desired activity is isolated (Rimando et al., 2001).  The  general  scheme  for  
carrying  out  a  bioassay  guided  fractionation  is summarized in figure 2.5 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 2.5: General scheme for bioassay guided isolation of active compounds ( Rimando  et 
al.,2000) 
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2.8.7 Characterization and structure elucidation of isolated 
compounds 
 
Once the biological evaluation has been performed and the separation of the natural product has 
been achieved, the chemist will try to attempt the elucidation of the compound. Structure elucidation   
depends on classical spectroscopic   techniques   such as:  Nuclear Magnetic Resonance (NMR) 1-D 
and 2-D HNMR as well as C-13 NMR, Infra-Red (IR), Mass Spectrometry (MS) and X-Ray analysis 
(Harborne, 1998). 
 
30 
 
 
 
 
 
2.9 LITERATURE CITED 
 
ARAVINDARAM, K. and YANG, N., 2013. Metabolomics in Medicinal Plant 
Research.Biotechnology for Medicinal Plants. Springer, pp. 275-294. 
BECKONERT, O., KEUN, H.C., EBBELS, T.M., BUNDY, J., HOLMES, E., LINDON, J.C. and 
NICHOLSON, J.K., 2007. Metabolic profiling, metabolomic and metabonomic procedures for 
NMR spectroscopy of urine, plasma, serum and tissue extracts. Nature protocols, 2(11), pp. 
2692-2703. 
BELEMTOUGRI, R.G., DZAMITIKA, S.A., OUEDRAOGA, Y., and SAWADOGO, L., 2007. 
Effects of water crude leaf extract of Sclerocarya birrea (A. Rich) Hocths (Anarcardiaceae)   on 
normotensive   rat   blood   pressure.   Journal   of Biological   Science 7(3), pp. 570-574 
BOHM, B., 1998. Introduction to flavonoids. Amsterdam: Harwood Academic Publishers. 
             236 
BRUNETON, J., 1999. Pharmacognosy, Phytochemistry and Medicinal Plants. Intercept. Ltd. 
England, United Kingdom. 
CERASI, E., 2000. Type 2 diabetes: To stimulate or not to stimulate the cell. Metabolism, 49(10), pp. 
1-2.  
CHEN, F., DURAN, A.L., BLOUNT, J.W., SUMNER, L.W. and DIXON, R.A., 2003. Profiling 
phenolic metabolites in transgenic alfalfa modified in lignin biosynthesis. Phytochemistry, 64(5), 
pp. 1013-1021.  
CHENG, A. Y. Y., and FANTUS, I. G., 2005.Oral antihyperglycemic therapy for Type II 
diabetes mellitus. Canadian Medical Association Journal, 172, pp. 213-226. 
 
CHEYNIER, V., 2005. Polyphenols in foods are more complex than often thought. American. 
Journal of Clinical nutrition. 81(supplimental.), pp. 223S-229S. 
 
COWAN,   M.M.,  1999.  Plant  products  as  antimicrobial  agents.  Clinical  Microbiology Review 
(12), pp.564–582. 
 
 
31 
 
 
 
 
 
DAYKIN, C.A., FOXALL, P.J., CONNOR, S.C., LINDON, J.C. and NICHOLSON, J.K., 2002. The 
comparison of plasma deproteinization methods for the detection of low-molecular-weight 
metabolites by 1 H nuclear magnetic resonance spectroscopy. Analytical Biochemistry, 304(2), 
pp. 220-230.  
 
DEFERNEZ, M. and COLQUHOUN, I.J., 2003. Factors affecting the robustness of metabolite 
fingerprinting using 1 H NMR spectra. Phytochemistry, 62(6), pp. 1009-1017. 
DETTMER, K., ARONOV, P.A. and HAMMOCK, B.D., 2007. Mass spectrometry‐based 
metabolomics. Mass spectrometry reviews, 26(1), pp. 51-78.  
DIMO,  T., RAKOTONIRINA, S.V., TAN, P.V., AZAY, J., and DONGO, E., 2007, Effects of 
Sclerocarya birrea (Anacardiaceae ) stem-bark methylene chloride/methanol extract on 
streptozotocindiabetic rats, 110 (3),pp.434-438. 
 
DOMON, B. and AEBERSOLD, R., 2010. Options and considerations when selecting a quantitative 
proteomics strategy. Nature biotechnology, 28(7), pp. 710-721. 
 
DOUGHARI, J.H., 2012. Phytochemicals: Extraction methods, basic structures and mode of 
action as potential chemotherapeutic agents. INTECH Open Access Publisher. 
 
ELOFF, J.N., 2001. Antibacterial activity of Murula (Sclerocarya birrea (A. rich) Hochst. Subsp. 
Caffra (Sond) Kokwaro) (Anacardiaceae) bark and leaves. Journal of Ethnopharmacology, 
(76), pp. 305–308. 
 
ELOFF,  J.N.,  1998.  Which  extractant  should  be  used  for  screening  and  isolat ion  of 
antimicrobial components from plants? Journal  of Ethnopharmacology, ( 60), pp.1-8. 
 
EROMOSELE, I. C., EROMOSELE, C.O., and KUZHKUZHA, M., 1991. Evaluation of mineral 
elements and ascorbic acid contents in fruits of some wild plants. Plant  foods for human 
nutrition, ( 41),pp.151-154. 
 
FAN,  T.W.,  BANDURA,  L.L., HIGASHI, R.M. and LANE, A.N., 2005. Metabolomics- edited 
transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics, 
1(4), pp. 325-339. 
32 
 
 
 
 
 
FORSHED, J., TORGRIP, R.J., ÅBERG, K.M., KARLBERG, B., LINDBERG, J. and 
JACOBSSON,  S.P., 2005. A comparison of methods for alignment of NMR peaks in the 
context of cluster analysis. Journal  of pharmaceutical  and biomedical  analysis,  38(5), pp. 
824-832. 
 
GALVEZ, J.,  CRESPO,  M.E.,  ZARZUELO,  A.,  DE  WITTE,  P.,  and  SPIESSENS,  C., 1993. 
Pharmacological activity of a procyanidin isolated from Sclerocarya birrea bark: 
Antidiarrhoeal activity on isolated Guinea-pig ileum. Phytotherapy Research, ( 7) ,pp. 25-28. 
 
GALVEZ, J.,  ZARZUELO,  A.,  BUSSON,  R.,  COBBAERT,  C.,  and  DE  WITTE,  P., 1992.  
(−)-Epicatechingalloyl  ester:  a secretagogue  compound  from  bark  of Sclerocarya birrea. 
Planta Medica (58), pp.174–175. 
 
GALVEZ,   J.,   ZARZUELO,   A.,   CRESPO,   M.E.,   UTRILIA,   M.P.,   JIMENEZ,   J., 
SPIESSENS,  C., and DE WITTE, P.,1991. Activity of Sclerocarya  birrea extract and its 
active tannin constituents in rats. Phytotherapy Research, ( 5), pp.276-278. 
GIBNEY, M.J., WALSH, M., BRENNAN, L., ROCHE, H.M., GERMAN, B. and VAN OMMEN, 
B., 2005. Metabolomics in human nutrition: opportunities and challenges. The American 
Journal of Clinical Nutrition, 82(3), pp. 497-503. 
 
GOUTAM,  B.,  and  DILIP,  G.,  2006.  Progress  in  the  research  on  naturally  occurring flavones 
and flavonols: An overview. Current Organic Chemistry, 10(8), pp.873-898. 
GRIFFIN, N.M., YU, J., LONG, F., OH, P., SHORE, S., LI, Y., KOZIOL, J.A. and SCHNITZER, 
J.E., 2010. Label-free, normalized quantification of complex mass spectrometry data for 
proteomic analysis. Nature biotechnology, 28(1), pp. 83-89.  
GURIB-FAKIM, A., 2006. Medicinal plants: Traditions of yesterday and drugs of 
tomorrow.Molecular Aspects of Medicine, 27 (2006),pp. 1–93. 
 
HANNAN,  J.M.A., ALI, L., ROKEYA, B., KHALEQUE, J., AKHTER, M., FLATT, P.R., and 
ADDEL-WAHAB, Y.H.A., 2007. Soluble dietary fibre fraction of Trigonella foenum- 
gracecum  (fenugreek)  seed improves glucose homeostasis  in animal models of type 1 and 
Type II diabetes by delaying carbohydrate digestion and absorption and enhancing insulin 
action. British Journal of Nutrition, (97), pp. 514-521. 
33 
 
 
 
 
 
HARBORNE, J.B.,  and  WILLIAMS,  C.A.,  2001.  Anthocyanins  and  other  flavonoids.Natural 
Product. Rep(18),pp.310-333. 
HARBORNE, J.B., 1998. Phytochemical methods a guide to modern techniques of plant analysis. 
Springer Science & Business Media.  
HATADA, K. and KITAYAMA, T., 2004. NMR spectroscopy of polymers. Springer Science & 
Business Media.  
HEINRICH, M., Barnes, J., Gibbons, S., and Williamson, E.M., 2004. Fundamentals of 
Pharmacognosy and Phytotherapy. Churchill Livingstone, Elsevier Science Ltd., United Kingdom. 
 
HOLLMAN, P.C., and KATAN, M.B., 1999. Health effects and bioavailability of dietary 
flavonols. Free Radical Research (31), pp. S75–S80. 
 
HUR, M., CAMPBELL, A.A., ALMEIDA-DE-MACEDO,  M., LI, L., RANSOM, N., JOSE, A.,  
CRISPIN,  M.,  NIKOLAU,  B.J.  and  WURTELE,  E.S.,  2013.  A  global  approach  to 
analysis  and  interpretation  of metabolic  data for  plant  natural product  discovery.  Natural 
product reports, 30(4), pp. 565-583. 
JADHAV, U., CHIGURUPATI, S., LAKKA, S.S. and MOHANAM, S., 2004. Inhibition of matrix 
metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular 
endothelial cells. International journal of oncology, 25(5), pp. 1407-1414.   
JANTAN, I., 2004. Medicinal plant research in Malaysia: scientific interests and advances. Jurnal 
Sains Kesihatan Malaysia, 2(2), pp. 27-46.  
JOHNSON, B.A. and BLEVINS, R.A., 1994. NMR View: A computer program for the visualization 
and analysis of NMR data. Journal of Biomolecular NMR, 4(5), pp. 603-614.  
JONES, W.P. and KINGHORN, A.D., 2005. Extraction of plant secondary metabolites. Natural 
products isolation. SKINGHORN, A.D. and BALANDRIN, M.F., 1993. Human medicinal 
agents from plants. American Chemical Society (ACS).  
KAUL, T.N., MIDDLETON, E. and OGRA, P.L., 1985. Antiviral effect of flavonoids on human 
viruses. Journal of medical virology, 15(1), pp. 71-79. 
34 
 
 
 
 
 
KIM, H.K., CHOI, Y.H. and VERPOORTE, R., 2010. NMR-based metabolomic analysis of plants. 
Nature Protocols, 5(3), pp. 536-549. pringer, pp. 323-351.  
KIM, H.K. and VERPOORTE, R., 2008. Sample preparation for plant metabolomics. Phytochemical 
Analysis, 21(1), pp. 4-13.  
KRISHNAN, P., JOSHI, D., NAGARAJAN, S. and MOHARIR, A., 2004. Characterisation of 
germinating and non-germinating wheat seeds by nuclear magnetic resonance (NMR) 
spectroscopy. European Biophysics Journal, 33(1), pp. 76-82.  
KRISHNAN, P., KRUGER, N.J. and RATCLIFFE, R.G., 2005. Metabolite fingerprinting and profiling 
in plants using NMR. Journal of experimental botany, 56(410), pp. 255-265.  
KUMARI, A., YADAV, S.K. and YADAV, S.C., 2010. Biodegradable polymeric nanoparticles based 
drug delivery systems. Colloids and Surfaces B: Biointerfaces, 75(1), pp. 1-18.  
LAPORNIK, B., PROŠEK, M. and WONDRA, A.G., 2005. Comparison of extracts prepared from 
plant by-products using different solvents and extraction time. Journal of Food Engineering, 
71(2), pp. 214-222.  
LIANG, Y., CHOI, Y.H., KIM, H.K., LINTHORST, H.J. and VERPOORTE, R., 2006. Metabolomic 
analysis of methyl jasmonate treated Brassica rapa leaves by 2-dimensional NMR spectroscopy. 
Phytochemistry, 67(22), pp. 2503-2511.  
LOMMEN, A., WESEMAN, J.M., SMITH, G.O. and NOTEBORN, H.P., 1998. On the detection of 
environmental effects on complex matrices combining off-line liquid chromatography and 1H-
NMR. Biodegradation, 9(6), pp. 513-525.  
MAHER, A.D., ZIRAH, S.F., HOLMES, E. and NICHOLSON, J.K., 2007. Experimental and 
analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping 
studies. Analytical Chemistry, 79(14), pp. 5204-5211.  
MANACH, C., SCALBERT, A., MORAND, C., RÉMÉSY, C., AND JIMENEZ, L., (2004). 
Polyphenols:  food sources and bioavailability.   The American Journal  of clinical nutrition, 
(79),pp.727-747. 
35 
 
 
 
 
 
MATTHAEI, S., STUMVOLL, M., KELLERER, M. and HARING, H., 2000. Pathophysiology and 
pharmacological treatment of insulin resistance 1. Endocrine reviews, 21(6), pp. 585-618.  
NIKHAL, S., DAMBE, P., GHONGADE, D. and GOUPALE, D., 2010. Hydroalcoholic extraction of 
Mangifera indica (leaves) by Soxhletion. International Journal of Pharmaceutical Sciences, 
2(1), pp. 30-32.  
OGBOBE, O., 1992.  Physico-chemical  composition  and characteristics  of the seed and seed oil 
of Sclerocarya birrea. Plant Foods for Human Nutrition, (42),pp. 201-206. 
 
 OJEWOLE, J.A., 2003. Evaluation of the analgesic anti‐inﬂammatory and anti‐diabetic   
properties of Sclerocarya  birrea (A. Rich.) Hochst. stem‐bark aqueous extract in mice 
and 
rats. Phytotherapy Research, 18(8), pp. 601-608. 
 
OJEWOLE, J.A., 2004. Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia 
frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Methods and 
findings in experimental and clinical pharmacology 26(6),pp.409-416. 
OKWU, D., 2001. Evaluation of chemical composition of indeginous species and flavouring agents. 
Global Journal of Pure and Applied Sciences, 7(3), pp. 455-460.  
OTTIGER, M. and BAX, A., 1999. Bicelle-based liquid crystals for NMR-measurement of dipolar 
couplings at acidic and basic pH values. Journal of Biomolecular NMR, 13(2), pp. 187-191.  
PERRETT, S., WHITFIELD, P.J., SANDERSON, L., AND BARTLET,  A., 1995. The plant 
mulluscicide Millenttia thonningii (Leguminoceae) as a topical antihistosomal agent. Journal 
of Ethnopharmacology ( 47), pp. 49-54. 
 
PIETA,   P.G., 2000.  Flavonoids as antioxidants.  Journal  of Natural  Products,  ( 63),pp.1035-
1042. 
 
PRETORIUS, V., ROHWER, E., RAPP, A., HOLTZHAUSE, L.C., AND MANDERY, H., 1985. 
Volatile components of marula Sclerocarya birrea subsp. caffra juice. Zeitschrift fur 
Lebensmittel Untersuchung und Forschung, ( 181), pp. 458-461. 
 
36 
 
 
 
 
 
RIMANDO, A. M., M. Olofsdotter, S.O.D., and Dayan, F.E., 2001. Searching for rice 
allelochemicals: an example of bioassay-guided isolation. Agronomy. Journal, (93), pp.16–
20. 
 
SATYAJIT,  D.,  SARKER,  Z.,  LATIF,  A.,  AND  GRAY,  I.,  2006.  Natural  product 
isolation. Second edition,Humana Press Inc ISBN 1-59259-955-9. 
 
SCALBERT, A., BRENNAN, L., FIEHN, O., HANKEMEIER,  T., KRISTAL, B.S., VAN 
OMMEN,  B., PUJOS-GUILLOT,  E., VERHEIJ,  E., WISHART,  D. and WOPEREIS,  S., 
2009. Mass-spectrometry-based metabolomics: limitations and recommendations for future 
progress with particular focus on nutrition research. Metabolomics, 5(4), pp. 435-458. 
 
SCALBERT,   A.,   JOHNSON,   I.T.,   AND   SALTMARSH,   M.,   2005.   Polyphenols: 
antioxidants and beyond. American Journal of Clinical Nutrition, (81),pp.215S-217S. 
 
SCHRIPSEMA, J., 2010. Application of NMR in plant metabolomics: techniques, problems and 
prospects. Phytochemical Analysis, 21(1), pp. 14-21. 
SCRIPSEMA, N.K. KRISHNAN, P., and ROSEN, R.B., 2009. Sample preparation for metabolomics 
research.  
SMITH,  G.C.,  CLEGG, M.S., KEEN, C.L., AND GRIVETTI, L.E., 1996. Mineral values of 
selected plants foods common to Southern Burkina Faso and to Niamey, Niger, West 
Africa.International Journal of Food Science and Nutrition, (47),pp. 41-53. 
SNYDER, L.R., 1968. Principles of adsorption chromatography; the separation of nonionic organic 
compounds.  
STREET, R. and PRINSLOO, G., 2012. Commercially important medicinal plants of South Africa: a 
review. Journal of Chemistry, 2013.  
SUDJAROEN, Y., HULL, W.E., ERBEN, G., WÜRTELE, G., CHANGBUMRUNG, S., ULRICH, 
C.M. and OWEN, R.W., 2012. Isolation and characterization  of ellagitannins as the major 
polyphenolic components of Longan (Dimocarpus longan Lour) seeds. Phytochemistry, (77), 
pp. 226-237. 
37 
 
 
 
 
 
TIZIANI, S., EMWAS, A., LODI, A., LUDWIG, C., BUNCE, C.M., VIANT, M.R. and GÜNTHER, 
U.L., 2008. Optimized metabolite extraction from blood serum for 1 H nuclear magnetic 
resonance spectroscopy. Analytical Biochemistry, 377(1), pp. 16-23.  
TORGRIP,  R.,  ÅBERG,  K.,  ALM,  E., SCHUPPE-KOISTINEN,  I. and LINDBERG,  J., 2008. 
A note on normalization of biofluid 1D 1H-NMR data. Metabolomics, 4(2), pp. 114-121. 
 
VAIDYA, A.B. and ANTARKAR, V.D., 1994. New drugs from medicinal plants: opportunities and 
approaches. The Journal of the Association of Physicians of India, 42(3), pp. 221-2, 227-8.  
 
VAN DE VENTER, M., ROUX, S., BUNGU, L.C., LOUW, C.N. R., OLWEN, M.G., MAHARAJ,  
V.,  PILLAY,  P.,  SEWNARIAN,  P.,  BHAGWANDIN,  N.,  AND  FOLB,  P., 2008. Anti-
diabetic screening and scoring of 11 plants traditionally used in South Africa. Journal of 
Ethnopharmacology, ( 119),pp. 81-86. 
 
VAN DER GREEF, J., HANKEMEIER, T. and MCBURNEY, R.N., 2006. Metabolomics-based 
systems biology and personalized medicine: moving towards n= 1 clinical trials 
 
VAN DER GREEF, J., DAVIDOV, E., VERHEIJ, E., VOGELS, J., VAN DER HEIJDEN, R., 
ADOURIAN, A.S., ORESIC, M., MARPLE, E.W. and NAYLOR, S., 2003. The role of 
metabolomics  in systems biology. Metabolic profiling:  Its role in biomarker  discovery and 
gene function analysis. Springer, pp. 171-198. 
 
 VAN  WYK,  B-E.,  VAN  OUDTSHOORN,  B.,  AND  GERICKE,  N.,  2000.  Medicinal plants of 
South Africa, 2nd ed. Briza Publications, Pretoria, South Africa 
 
VAN  WYK,  B-E.,  VAN OUDSTSHOORN,  B., AND GERICKLE  N., 1997. Medicinal plants of 
South Africa. Pretoria: Briza. pp. 214-215. 
 
VENTER, F., and VENTER, J.A., 1996. Making  the most of indigenous  trees. Briza 
Publications, Pretoria. 
 
VERPOORTE, R., CHOI, Y. and KIM, H., 2007. NMR-based metabolomics at work in  
38 
 
 
 
 
 
phytochemistry. Phytochemistry reviews, 6(1), pp. 3-14. 
 
VIANT,  M.R.,  2003. Improved  methods  for the acquisition  and interpretation  of NMR 
metabolomic data. Biochemical and biophysical research  communications, 310(3), pp. 943-
948. 
 
WATT,  J.M., AND BREYER-BRANDWIJK,  M.G., 1962. The Medicinal and Poisonous Plants 
of Southern and Eastern Africa. E.S. Livingstone, Edinburgh. 
WELJIE, A.M., NEWTON, J., MERCIER, P., CARLSON, E. and SLUPSKY, C.M., 2006. Targeted 
profiling: quantitative analysis of 1H NMR metabolomics data. Analytical Chemistry, 78(13), 
pp. 4430-4442. 
WIDARTO,  H.T.,  VAN  DER  MEIJDEN,  E., LEFEBER,  A.W.,  ERKELENS,  C.,  KIM,   H.K., 
CHOI, Y.H. and VERPOORTE,  R., 2006. Metabolomic  differentiation of Brassica rapa 
following herbivory by different insect instars using two-dimensional nuclear magnetic 
resonance spectroscopy. Journal of chemical ecology, 32(11), pp. 2417-2428. 
 
WILLIAMS, E.M., OKPATO, D.T., EVANS, F.J., 1996. Selection, preparation, and 
pharmacological evaluation of plant material. Willey & Sons LTD. ISBN 047194216-2. 
 
WILSON, C.W., 1980. Guava. In: S. Nagy and P.E. Shaw, Editors, Tropical and SubtropicalFruits:  
Composition,  Properties  and  Uses,  Avi  Publications,  Westport, Connecticut, United States 
of America pp.279–299. 
WURTELE, E.S., CHAPPELL, J., JONES, A.D., CELIZ, M.D., RANSOM, N., HUR, M., 
RIZSHSKY, L., CRISPIN, M., DIXON, P. and LIU, J., 2012. Medicinal plants: a public 
resource for metabolomics and hypothesis development. Metabolites, 2(4), pp. 1031-1059.  
YUAN, R. and LIN, Y., 2000. Traditional Chinese medicine: an approach to scientific proof and 
clinical validation. Pharmacology & therapeutics, 86(2), pp. 191-198.  
ZHANG,   A.,  SUN,  H.,  WANG,  P.,  HAN,  Y.  and WANG, X.,  2012.  Modern analytical 
techniques in metabolomics analysis. Analyst, 137(2), pp. 293-300. 
 
 
 
 
39 
 
 
 
 
 
3 
 
 
 
 
 
NMR based geographical characterization of 
 
Sclerocarya birrea methanol extracts 
 
 
 
 
 
 
3.1 Abstract 
 
Nuclear Magnetic Resonance (NMR) is frequently used as a technological platform for 
metabolomics   applications.  In this study the metabolic profile of S. birrea methanol leaf 
extracts from five different   provinces were recorded by 1H NMR.   When  mult ivariate  data  
analysis  was performed  on  1H NMR  results,  the  supervised  OPLS-DA  showed  the  samples  
having separated in three groups. The samples from Gauteng and those from KwaZulu-Natal 
separated away from those from Mpumalanga, Limpopo and North West. The samples from 
Mpumalanga, Limpopo and North West formed one large group, representing some similarities 
between the provinces. The contribution plots presented sugars to be metabolites important in the 
samples from Gauteng, and the phenolic metabolites as the ones important in the samples from 
KwaZulu-Natal. The samples from the other three provinces (Limpopo, Mpumalanga and North West) 
presented very few sugar metabolites as the most important ones in these samples. The applied approach 
appears to be a promising strategy in extending the analytical capacities of these metabolomics 
techniques with regard to the discovery and identification of biomarkers and yet unknown metabolites. 
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3.2 Introduction 
 
Humans have relied for ages on natural products for relief of pain and improvement of health. 
Specialized metabolites from plants serve as a rich resource for drug development.  The molecular 
and physiological effects of medicinal plant extracts and components are often characterized   in   
research   studies   of   mammalian   systems; almost   100   plant-derived compounds were included 
in clinical trials in 2007, and as of 2008, 68% of all pharmaceuticals were plant derived or plant 
inspired (Zhu et al., 2012). 
 
The stem bark, roots and leaves of S. birrea, has been used for decades as a traditional medicine.   
Sclerocarya birrea is mostly called “Marula” because of the stone found inside the fleshy fruit.  
The tree  has  been  evaluated  for  antibacterial  potential  (Eloff,  2001),  hypoglycemic potential 
(Ojewole, 2003), antiproliferative potential (Ndip and Tonih, 2013) and many other human aliments 
(Van Wyk et al., 2000).  Amongst all the medicinal uses presented above, S. birrea is mostly 
studied for its anti-diabetic potential. Currently, type II diabetes mellitus, the most common type 
of diabetes mellitus, is managed by a combination of diet, exercise, oral hypoglycemic drugs and 
sometimes insulin injections (Bailey, 2000). However, synthetic oral hypoglycemic drugs, which 
are currently the main form of treatment for type II diabetes mellitus have been shown to have 
detrimental side effects and high secondary failure rates ( Bailey ,2000; Erasto et al.,2005; Dey et 
al., 2007). 
 
In part because  they  lack  mobility,  plants  have  evolved  chemically-based  strategies  for defense 
and attraction  (Weng et al., 2012; Mithöfer and Boland , 2012). As a consequence, even low levels 
of thousands of metabolites that are synthesized across the plant kingdom interact with mammalian 
signaling networks via variety of molecular mechanisms.  However, metabolic diversity is poorly 
characterized for most species that are used medicinally and indeed for plants in general. In 
addition, understanding of the molecules and metabolic pathways that lead to the formation of 
already-known plant- derived medicinal compounds is still incomplete. Modeling of metabolism 
requires computational technologies integrated with informed biological understanding of 
metabolites and pathways. In the case of medicinal plants (i.e., non-model-species),  such  data  
are  scarce  and  difficult  to  integrate  into  a  meaningful biological framework.  
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One feature that can facilitate studies of plant metabolites and the corresponding pathways is that the  
content  and  profile  of  metabolite  accumulation  vary widely  with  developmental   stage,  cell  
and  tissue  type,   genotype,   and  environmental perturbation (Balandrin and Klocke, 1988; 
Crispin and Wurtele, 2013; Luca et al., 2012). A metabolomics-based analysis of natural products across 
multiple conditions is a first  step towards  elucidating  the  associated  metabolic  pathways  and  
identifying  metabolites found in the sample. In this study the differences in the chemical profiles of S. 
birrea from different regions were investigated, a n d  this was linked to the anti- diabetes 
potential of the extracts. 
 
3.3 Materials and methods 
 
3.3.1 Study sites and sample collection 
 
Leaf samples from 12 S. birrea trees were collected in October 2013, from each of the five sampling 
areas  Limpopo  (L),  Gauteng  (G),  North  West  (NW),  Mpumalanga  (M)  and KwaZulu-Natal 
(KZN) (Figure 3.1). From each province, two regions were identified for col lection, and in each 
region samples were collected from three different trees with two samples per tree. The origins of 
samples are summarized in table 3.1. The leaves were harvested from trees of almost the same 
height (9.5 m). The height of a tree was determined by implementing a method described by the 
Teachers notes on how to determine the height of the tree. In brief the method relies on 
trigonometry and the fact that if you view a tree top at 45 degree angle then the height of the tree 
is equivalent to the distance you are from that tree. 
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Figure 3. 1: A geographical map of Limpopo, Gauteng, North West, 
Mpumalanga and KwaZulu-Natal showing areas where S. birrea leaves were 
sampled.  
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Figure 3.2: Determination of a tree’s height 
http://www.saps.org.uk/attachments/article/141/SAPS_How_to_find_the_height_of_a
_tree.pdf. 
 
        Table 3.1. List of S. birrea leaf samples analyzed 
 
Sample Gender Region Province 
Skb 1-1 Male Ga- sekgoboko L 
Skb 1-2 Male Ga- sekgoboko L 
Skb 2-1 Male Ga- sekgoboko L 
Skb 2-2 Male Ga- sekgoboko L 
Skb 3-1 Male Ga- sekgoboko L 
Skb 3-2 Male Ga- sekgoboko L 
Mkp 1-1 Female Mookgophong L 
Mkp 1-2 Female Mookgophong L 
Mkp 2-1 Female Mookgophong L 
Mkp 2-2 Female Mookgophong L 
Mkp 3-1 Male Mookgophong L 
Mkp 3-2 Male Mookgophong L 
Bbl 1-1 Male Babelegi G 
Bbl 1-2 Male Babelegi G 
Bbl 2-1 Male Babelegi G 
Bbl 2-2 Male Babelegi G 
Bbl 3-1 Male Babelegi G 
Bbl 3-2 Male Babelegi G 
Jbl 1-1 Male Outside Jubilee mall G 
Jbl 1-2 Male Outside Jubilee mall G 
Jbl 2 -1 Male Outside Jubilee mall G 
Jbl 2-2 Male Outside Jubilee mall G 
Jbl 3-1 Female Outside Jubilee mall G 
Jbl 3-2 Female Outside Jubilee mall G 
Ntb 1-1 Female Ntibane game range KZN 
Ntb 1-2 Female Ntibane game range KZN 
Ntb 2-1 Female Ntibane game range KZN 
Ntb 2-2 Female Ntibane game range KZN 
Ntb 3-1 Male Ntibane game range KZN 
Ntb 3-2 Male Ntibane game range KZN 
Mhl 1-1 Female Mahlalela game range KZN 
Mhl 1-2 Female Mahlalela game range KZN 
Mhl 2-1 Female Mahlalela game range KZN 
Mhl 2-2 Female Mahlalela game range KZN 
Mhl 3-1 Female Mahlalela game range KZN 
Mhl 3-2 Female Mahlalela game range KZN 
Ltl 1-1 Female Lethlabile NW 
Ltl 1-1 Female Lethlabile NW 
Ltl 1-1 Male Lethlabile NW 
Ltl 1-1 Male Lethlabile NW 
Ltl 1-1 Female Lethlabile NW 
Ltl 1-1 Female Lethlabile NW 
Kgb 1-1 Male Kgabalatsane NW 
Kgb 1-2 Male Kgabalatsane NW 
Kgb 2-1 Female Kgabalatsane NW 
Kgb 2-2 Female Kgabalatsane NW 
Kgb 3-1 Female Kgabalatsane NW 
Kgb 3-2 Female Kgabalatsane NW 
ARC 1-1 Female ARC-Nelspruit M 
ARC 1-2 Female ARC-Nelspruit M 
ARC 2-1 Male ARC-Nelspruit M 
ARC 2-2 Male ARC-Nelspruit M 
ARC 3-1 Female ARC-Nelspruit M 
ARC 3-2 Female ARC-Nelspruit M 
Mcd 1-1 Female Machadodorp M 
Mcd 1-2 Female Machadodorp M 
Mcd 2-1 Male Machadodorp M 
Mcd 2-2 Male Machadodorp M 
Mcd 3-1 Female Machadodorp M 
Mcd 3-2 Female Machadodorp M 
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3.3.2 Sample preparation for NMR spectroscopy 
 
3.3.2.1 Methanol extracts preparation 
 
NMR analysis was done on a Bruker 600 MHz spectrometer (Wageningen University, The 
Netherlands) operating at a proton NMR frequency of 600.13 MHz. 15mg of the dried leaf 
material was dissolved in 400µl methanol-D4. The mixture was sonicated for 20 minutes and then 
centrifuged  for  10  minutes  at  10  000  rpm,  room  temperature,  and  200  µl  of  the supernatant 
was transferred to standard 3-mm NMR tubes. Gradient shimming was used to improve the 
magnetic field homogeneity prior to all acquisition. All spectra were Fourier- transformed, phase-
corrected and baseline- corrected manually. 
 
3.3.2.2 Multivariate data analysis 
 
The  
1
H  NMR  spectra  were  reduced  to  ASCII  files  using  Mestrenova  9.0.  (Mestrelab 
Research). The region of 0.00- 10.00 ppm was reduced to bins 0.04 ppm in width. The region ranging 
from 3.28-3.36 ppm (residual MeOH) and 4.60-5.00 ppm (residual water) were removed prior to 
statistical analyses. The ASCII files generated were then imported into Microsoft Excel 2010 for 
secondary variable labeling after which the files were imported into Simca version 13.0  (Umetrics  
Umea, Sweden).  The data was Pareto scaled before being subjected to PCA and OPLS-DA 
analysis. 
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3.4 Results and Discussion 
 
3.4.1 1H NMR analysis of S. birrea methanol extracts 
 
For the metabolomics analysis, all the extracts were analyzed under the same condition to limit 
technical errors in the data generated. All the 60 samples as mentioned in table 3.2.1 above 
were subjected to Metabolomic analysis. 
 
The NMR spectra appeared as a complex ensemble of resonances, indicating the presence of 
multitude of metabolites (Figure 3.3). In addition, given the presence of resonances throughout the 
whole spectra width (0-8 ppm), variable chemical features ranging from aliphatic to aromatic 
groups were detected in the extracts. In particular, intense signals in the sugar region mostly in the 
samples from Gauteng were observed, indicating the presence of glycosylated metabolites and free 
sugars (Figure 3.4). From the visual comparison of the spectra, there is an obvious similarity 
between all spectra, suggesting similar metabolic profiles between S. birrea from different 
provinces. 
 
The analysis of S. birrea   leaf extracts from five provinces by 1H NMR allowed the detection of 
essentially primary (polar) metabolites such as sugars, amino acids, and organic acids, and the 
abundance of the corresponding resonances indicated the high natural concentration of these 
metabolites in the leaves. The relatively low abundance of secondary metabolites and the large 
amount of resonances in the spectrum made the detection of secondary metabolites, such as phenolic 
acids, flavonoids and alkaloids, more difficult as compared to the detection of the primary 
metabolites. Based on these NMR profiles, the relative differences between the S. birrea from 
different provinces were visualized by plotting the scores of a principal component analysis. 
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Figure 3.3: 1H NMR spectra for sixty methanol extracts of S. birrea 
 
 
Figure 3.4: Average spectra of sixty methanol extracts of S. birrea 
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3.4.2 Metabolomic analysis of Sclerocarya birrea extracts from different 
provinces 
 
To provide comparative interpretation and visualization of the fundamental variations and metabolite 
differences in the samples from different origins, Principal Component Analysis (PCA) and 
Orthogonal Partial Least square- Discriminant Analysis (OPLS-DA) were applied to the 1H NMR 
spectrum dataset. The PCA showed more significant differences between KZN, L, NW and M, than 
between KZN and G (Figure 3.5).  The PCA model for distinguishing S. birrea samples obtained 
from different origins was established using seven components and revealed R2X and Q2 values of 
0.85 and 0.78 respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Score plot of PCA-X performed by considering all 60 methanol samples. 
The red dots represent samples from KZN;  blue  represent samples  from G;  
yellow represent samples  from NW;  green represent  samples  from L  and  light  
blue represent samples from M. 
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To improve the clustering and to identify the metabolites responsible for the differences between the 
provinces, OPLS-DA model was constructed (Figure 3.6), and revealed RY2 and Q2 values of 0.73 
and 0.62 respectively. The samples from five provinces were clearly separated in the OPLS- DA 
score plot (Figure 3.6), which means that the non-correlated variation in X metabolites to Y 
metabolites was removed, resulting in maximum separation.  This maximum separation also 
indicates that the levels of S. birrea metabolites were strongly influenced by the various growing 
conditions in each region. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 3.6: Score plot of OPLS-DA performed by considering all 60 methanol 
sample. The red dots represent samples from KZN; blue represent samples from 
G; yellow represent samples from NW; green represent samples from L and light 
blue represent samples from M. 
 
 
Clustering into five groups were observed, according to the provinces indicates that there are some 
metabolites unique between the provinces. The samples from Gauteng and KwaZulu-Natal presented 
the greatest differences in that they were both further apart from the others. When the contribution plots 
were constructed on the samples from Gauteng, it was clear that the sugars contributed to the  
differences between Gauteng and other provinces. The sugar region in the peaks in the positive bars of 
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the contribution plots of Gauteng (Figure 3.7) is more abundant than the aliphatic and the aromatic 
regions indicating the importance of sugars in samples from Gauteng than in the others. Using 
Chenomx,   the metabolites important in Gauteng were annotated in table 3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Contribution plots generated by comparing samples from Gauteng to 
those from Limpopo, North West, KwaZulu-Natal and Mpumalanga. The buckets 
(positive bars) represent the specific regions of the S. birrea NMR spectra responsible 
for the differences. The negative bars represent the areas important in the other four 
provinces while the positive bars represent the ones important in Gauteng. 
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Figure 3.8: Contribution plots generated by comparing samples from KwaZulu-Natal 
to those from Limpopo, North West, Gauteng and Mpumalanga. The buckets 
(positive bars) represent the specific regions of the S. birrea NMR spectra responsible 
for the differences. The negative bars represent the areas important in the other four 
provinces while the positive bars represent the ones important in KwaZulu-Natal. 
 
In addition to the sugars presented by the contribution plots in Gauteng, the samples from KwaZulu-
Natal showed very few sugars, few aliphatic and more aromatics to be important in the samples from 
this province (Figure 3.8), the metabolites important to KwaZulu-Natal are annotated in table 3.2. 
Visual inspection of the contribution plots from both KwaZulu-Natal and Gauteng confirms that the 
samples from Gauteng are rich with sugars while those from KwaZulu-Natal are rich in aromatic 
metabolites.  
 
It can therefore be concluded that the separation of samples from Gauteng to those from KwaZulu-
Natal, Limpopo, Mpumalanga and North West is influenced by the sugars while the separation of 
samples from KwaZulu-Natal to those from the other four provinces is mostly influenced by aromatics, 
some aliphatic, and  some sugars. In the OPLS-DA scores (figure 3.6), the three provinces 
(Mpumalanga, Limpopo, and North West) showed the closest similarity in that their separation was not 
clear (Figure 3.6). To confirm that  in deed the samples are similar, the samples from Gauteng and those 
from KwaZulu-Natal were excluded from the dataset and the comparison was only between Limpopo, 
Mpumalanga and North West (Figure 3.9). The, OPLS-DA model constructed between the three 
Provinces (Limpopo, Mpumalanga and North West), revealed RY2 and Q2 values of 0.73 and 0.63 
respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51
42 
 
 
 
 
  
 
 
 
Figure 3.9: OPLS-DA scores performed by considering samples from Limpopo 
(green), North West (yellow) and Mpumalanga (Light blue).  
 
 
When the contribution plots were performed on the samples in Figure 3.9, Mpumalanga appeared to 
have more aromatics as the metabolites of importance in the province (Figure 3.10).  The other two 
provinces (Limpopo, and North West) presented aliphatic as the important metabolites as opposed to 
aromatics in Mpumalanga. The metabolites are annotated in table 3.2.  All the phenolic metabolites 
annotated  in this chapter were previously identified in the cultivated and wild Sclerocarya birrea leaves  
by Braca et al (2003).  The metabolites annotated in table 3.2 are shown in figure 3.12 below. There is a 
great difference in the levels of metabolites between the provinces; therefore the medicinal properties of 
this plant from different provinces can be expected to differ. 
 
 
 
 
Figure 3.10: Contribution plots generated by comparing samples from Mpumalanga 
to those from Limpopo, and North West. The buckets (positive bars) represent the 
specific regions of the S. birrea NMR spectra responsible for the differences. The 
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negative bars represent the areas important in Limpopo and in North West provinces 
while the positive bars represent the ones important in Mpumalang 
 
 
Table 3.2 Metabolites with the highest intensities from the contribution plots and their 1H 
NMR chemical shifts 
 
 
 
Overall all provinces presented   the metabolites as unique to each.  The sugar region in Gauteng was so 
unique in that the differences were observed even on the spectra itself before the statistical analysis with 
Simca. To confirm that the sugar region was mostly important in the samples from Gauteng, the region 
was excluded from the dataset and the OPLS-DA scores (Figure 3.11) with four components with R2X 
and Q2 values of 0.61 and 0.47 respectively was observed. The samples from KwaZulu-Natal are 
furthest away from the rest (Figure 3.11). No clustering of KwaZulu-Natal, Gauteng, Limpopo or North 
West is observed, supporting the importance of the sugars in clustering of the samples. Very few 
samples from KwaZulu-Natal grouped with the samples from Limpopo, North West, Mpumalanga and 
Gauteng.  This is mostly because of the lower concentration of sugars present in the samples which was 
Province Metabolite Chemical shift(multiplicity
a
)
Gauteng Lactate 1.32(d) 4.05(q)
Glutamate 2.04(m) 2.34 (m)
*Sucrose 3.44(t) 3.76(t) 3.54(dd) 5.39(d) 4.17(d)
Fructose 3.94(m) 3.51(d) 4.01(dd) 3.65-3.72(m) 3.77-3.87(m)
Alanine 1.46(d) 3.70(q)
KwaZulu-Natal *Lactate 1.32(d) 4.05(q)
Alanine 1.46(d) 3.70(q)
Sucrose 3.44(t) 3.76(t) 3.54(dd) 5.39(d)
Kaempferol 3-0 -α-L-rhamnopyranoside 6.38(d) 6.20(d) 6.95(d)
Phenylalanine 7.32(m) 7.39(m)
Gallic acid 7.04(s)
(-)-Epicatechin 3-0-galloyl ester 6.90(d) 6.82(dd)
Myricetin 3-0-α-L-rhamnopyranoside 6.12(d) 5.31(d)
Quercetin 3-0-β-D-glucopyranoside 6.16(d) 5.10(dd) 6.85 (dd)
Quercetin 3-0-β-D-(6''galloyl)glucopyranoside 6.18(d) 5.40(d) 6.36(dd)
Limpopo, North West *Fructose 3.94(m) 3.51(d) 4.01(dd) 3.65-3.72(m) 3.77-3.87(m)
sucrose 3.44(t) 3.76(t) 3.54(dd) 5.39(d) 4.17(d)
unknown 1.16 (m)
Mpumalanga *Malate 4.26(dd) 2.34(dd) 2.65 (dd)
Sucrose 3.44(t) 3.76(t) 3.54(dd) 5.39(d) 
Glutamate 2.04(m) 2.34 (m)
Kaempferol 3-0-α-L-rhamnopyranoside 6.38(d) 6.20(d) 6.95(d)
Acetate 1.90 (s)
Leucine 0.96(d) 0.97 (d) 1.70(m)
unknown 9.44(t)
(-)-Epigallocatechin 3-0 -galloyl ester 5.56(s) 6.03(d) 6.06(d)
Gallic acid 7.04(s)
 
a
 Letters parenthes denotes the peak multiplicity:  s, singlet; d, doublet; t, triplet; dd, doublet of doublet; q,quarted; and m, multiplet
* denotes the peak with the highest intensity in the contribution plots
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also observed in the contribution plots from KwaZulu-Natal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.11:  The score plot of samples from five provinces with exclusion of the sugar 
region. (3-4 ppm) 
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Figure 3.13: Metabolites annoted by NMR from S. birrea leaves; A= Lactate, 
B=Glutamate, C=Sucrose, D=Alanine, E=Malate, F= Myricetin, G= Quercetin, H= 
Kaempferol and I=Gallic acid, (chemspider) 
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3.5 Concluding remarks 
 
 
 In this study, methanol extracts of S. birrea from different provinces were compared and 
characterized based on multivariate statistical analysis of 1H NMR –based metabolomics data. 
Many of the primary metabolites (sugars) and few secondary metabolites (phenolics) were 
identified. Sclerocarya birrea from different provinces exhibited significant differences in their 
metabolite profiles confirming that several metabolites can be used as markers for origin. The samples 
also showed some close similarities, in that some metabolites (sucrose and lactate) were found to be 
important in the samples from all five provinces, as confirmed by the contribution plots. The most 
significant difference   was with   regard   to the   primary metabolites, specifically the sugar   region   
influenced   by glycosylation in the samples from Gauteng. KwaZulu-Natal presented a relatively 
high amount of phenolic metabolites. The removal of the sugar region resulted in the Gauteng 
samples mixing with the samples from Mpumalanga, North West and Limpopo with no clustering. 
Therefore, although there are close similarities, there are also compounds which are unique from 
these provinces. For better understanding of the differences and similarities, a more sensitive 
technique like LC-MS should be used for better detection of relatively low abundance secondary 
metabolites which can be responsible for the differences observed. In this chapter we demonstrated 
that 1H NMR-based profiling provides a fast and efficient method to fingerprint metabolic 
differences between same species of S. birrea grown in different regions. This analytical approach 
can be used to discriminate among origin of S. birrea and to identify primary and secondary 
metabolites responsible for discrimination. The next step in this study was to measure the same 
samples used in this study, with LC-MS with the aim to detect more secondary metabolites.  
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                 LC-MS based geographical characterization of 
        Sclerocarya birrea methanol extract 
 
 
 
 
4.1 Abstract 
 
The goal of metabolomics is to measure all the metabolites in an organism both qualitatively and 
quantitatively, which can provide a clear metabolic picture of a living organism under certain 
conditions. This is a very ambitious goal, as the plant metabolome is very complex and therefore no 
single technique is enough to study the whole metabolome of a plant. The same samples used for 1H 
NMR were use also for LC-MS measurements. The base peak chromatogram in LC-MS showed some 
similarities between the samples. The metabolite that can either be Myristicin or ‘1 Hydroxychavicol 
acetate annotated from Human metabolome database was present in all the samples with a m/z ratio 
of 191. The compounds m/z 381,171,289,261,453,418   contributed to the differences observed with 
PLS-DA in samples from five provinces. The multivariate data analysis with PLS-DA confirmed the 
samples to have some differences in metabolite profiles, in that they separated into five groups 
according to their places of origin.  
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4.2 Introduction 
 
LC-MS and NMR are distinct analytical techniques, concerning detection and sensitivity. LC-MS is a 
fast and sensitive technique when compared to NMR.  However,  the  separation  of metabolites  is 
dependent on the chromatographic  column used, the detection is dictated by the  ionization  ability  
of  the  analytes  and  the  molecular  elucidation  has  some  intrinsic limitations, such as the 
resolution of isomers (Moco et al., 2008). NMR is indiscriminative towards matrix properties, given 
that the analytes are soluble.  NMR is a highly selective technique for distinguishing molecular 
structures, but has a lower sensitivity compared to MS (Moco et al., 2007a).  The statistical  
combination  of  metabolomics  data  from  profiling equivalent samples by NMR and LC-MS opens 
opportunities to relate spectrometric and spectroscopic properties for single metabolites. These 
statistical strategies have been applied to large-scale analytical analyses of urine (Crockford et al., 
2006; Forshed et al., 2007a, b). 
 
Beyond the analytical acquisition of data, the interpretation of metabolomics data is highly dependent 
on the performed data analysis. Due to the production of large datasets and complexity of untargeted 
metabolic fingerprinting techniques, appropriate conclusions arise only after preprocessing and 
statistical validation of metabolomics datasets (Moco et al .,2008). Multivariate analyses methods are 
useful in discriminating information, dealing with the redundancy often present in metabolomics data 
(Trygg et al., 2007). One of the statistical methods to establish  relationships  between  metabolite  
signals  belonging  to  a  biological system is correlation analysis. The presence of high correlations 
in metabolomics data can be attributed to several phenomena which might not be directly related to 
pathway proximity (Camacho et al., 2005; Steuer, 2006). It has been proposed that the highest 
correlations belong to either an equilibrium situation (positive correlations) or to a mass conservation 
situation in which there is a moiety conserved cycle (negative correlations) (Camacho et al. 2005; 
Steuer, 2006). Both MS (Fraser et al., 2007; Moco et al., 2006a; Schauer et al., 2005; Tikunov et 
al.,2005) and NMR (Le Gall et al., 2003; Mattoo et al., 2006; Mounet et al. 2007) have previously 
been used for the profiling of metabolites in various plant species. In the present study, we used  LC-
QTOF-MS  techniques  to  record  the  metabolic  profiles  of  60  S. birrea  leaf samples from five 
different provinces. 
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4.3 Materials and method 
 
4.3.1 Study site and sample collection 
 
The same samples as the ones used in chapter 3 where used for LC-MS measurements and 
analysis. 
 
4.3.2 Sample preparation for LC-MS spectroscopy 
 
4.3.2.1 Methanol extracts preparation. 
 
The remaining 200 µl from samples used in chapter 3 was used in carrying out LC-MS 
measurements. The operating parameters were; end plate offset, -v; capillary voltage, 3.5kv; dry 
gas, 8.0L min
-1
; dry temperature, 200ºC. The samples were analyzed in negative mode. 
 
4.3.3 Multivariate data analysis 
 
Quantification of S. birrea metabolite profiles of LC-MS analyses was performed using XCMS 
online data analysis software, which can be accessed freely from the Scripps Centre For 
Metabolomics (https://xcmsonline.scripps.edu).  This software approach employs peak alignment, 
matching and comparison (Smith et al., 2006). The raw LC-MS files were first converted to 
Mzxml files using MS convert.    Peaks were subsequently extracted using XCMS.  The final 
statistical analysis where performed by employing MetaboAnalyst  3.0- a comprehensive tool 
suite for metabolomic data analysis, which also can be accessed freely from  
www.metaboanalyst.ca/MetaboAnalyst.  This software employs data normalization, multivariate 
analysis methods (PCA and PLS-DA), clustering analysis and many more analysis approaches. All 
the samples were auto scaled prior to the analysis. 
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4.4 Results and discussions 
  
 4.4.1 LC-MS base peak chromatogram in negative mode of S. birrea 
extracts 
 
Representative LC-MS base peak chromatograms of methanol S. birrea extracts from five provinces 
(L, G, NW, KZN and M) are shown in Figure 4.1 to 4.5. As to be expected, MS is more sensitive than 
NMR, which was made clear by the fact that visual inspection of the chromatograms did not give 
clear similarities as was observed with NMR. Visual inspection of the chromatograms showed that 
most metabolites in KZN are also available in G. The three other chromatograms for L, NW and M 
also showed some similarities in metabolites. This relationship in similarities complements the 
OPLS-DA obtained with NMR. When the samples are compared, L compares to both NW and MP 
and KZN compares well to G. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Base peak chromatogram of Sclerocarya birrea leaves from KwaZulu-
Natal. 
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Figure 4.2: Base peak chromatogram of Sclerocarya birrea leaves from Gauteng. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Base peak chromatogram of Sclerocarya birrea leaves from Limpopo. 
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Figure 4.4: Base peak chromatogram of Sclerocarya birrea leaves from North West. 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Base peak chromatogram of Sclerocarya birrea leaves from KwaZulu-Natal. 
 
Figure 4.2: Base peak chromatogram of Sclerocarya birrea leaves from Gauteng. 
 
Figure 4.3: Base peak chromatogram of Sclerocarya birrea leaves from Limpopo. 
 
 
Figure 4.4: Base peak chromatogram of Sclerocarya birrea leaves from North West. 
 
 
 
 
 
 
 
 
Figure 4.5: Base peak chromatogram of Sclerocarya birrea leaves from 
Mpumalanga. 
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More than 25 compounds were resolved, of which 13 were annotated; m/z 191 accounted for the 
highest abundance amongst the species (figure 4.1-4.5). Due to time limitation and scope of this 
study, it was not possible to annotate all the metabolites. The presence of the metabolite at m/z 191 
annotated as either Myristicin or ‘1Hydroxychavicol acetate in all the samples, confirms that this 
metabolite is one of the marker compounds in S. birrea species, the metabolites annotated with LC-
MS are provided in table 4.1 below, and their chemical structures are shown in figure 4.6. Samples 
from Mpumalanga lacked the metabolite Myricetin 3-0-α-L-rhamnopyranoside (m/z 463). This 
metabolite was previously reported to have anti-diabetes potential; the absence of this metabolite 
might have an effect on the activity of the leaves in the treatment of diabetes. Therefore, the anti-
diabetic activity of the leaves should be performed on samples from individual provinces. Should 
the samples from Mpumalanga not present any activity, then that will indicate that the metabolite 
Myricetin 3-0-α-L-rhamnopyranoside is not the key metabolite in anti-diabetes activity of the 
leaves and that other compounds might be more important contributors to the activity. 
 
Table 4.1: Compounds annotated in Sclerocarya birrea methanol  leaf extract by LC-MS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Province rt (min) Annotation [M-H]
-
 (m/z)
KwaZulu-Natal 27 Myricetin 3-0 -α-L-rhamnopyranoside 463.1138
25 2,3-dehydrosilybin 479.1078
34 Docosahexaenolic acid 327.2351
54.5 Unknown 265.1619
8.7 Myristicin/ '1 Hydroxychavicol acetate 191.0669
63 Unknown 174.9653
Limpopo 25.9 Unknown 647.1024
25.7 Myricetin 3-0 -α-L-rhamnopyranoside 463.1049
38.3 Unknown 287.2322
55.4 Atenolol 265.1574
8.7 Myristicin/ '1 Hydroxychavicol acetate 191.066
63.6 Unknown 174.9632
Gauteng 25.2 Myricetin 3-0 -α-L-rhamnopyranoside 463.1101
34.9 Ent-16-kauren-19-ol-acetate 329.2477
54.6 Atenolol 265.1604
8.7 Myristicin/ '1 Hydroxychavicol acetate 191.0689
64.3 Unknown 174.9646
North West 13.6 3,4,5-Trihydroxy-3'7 dimethoxyflavanone/3,5,7-Trihydroxy-4'6 dimethoxyflavanone 331.0865
20 Diospyrin 483.1049
25.6 Myricetin 3-0 -α-L-rhamnopyranoside 463.1165
35 Ent-16-kauren-19-ol-acetate 329.2529
54.5 Unknown 265.1629
8.7 Myristicin/ '1 Hydroxychavicol acetate 191.0689
63.5 Unknown 174.9669
Mpumalanga 27.9 Unknown 433.1029
40 Abietinol 287.2379
54.7 Unknown 265.1629
8.7 Myristicin/ '1 Hydroxychavicol acetate 191.0683
62.9 Unknown 174.967
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Figure 4.6: Metabolites annotated by LC-MS from S. birrea leaves; A=2,3 
dehydrosilybin, B=Docosahexaenolic acid, C=Myristicin and D=myricetin, ( 
Chemspider) 
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4.4.2 MS data processing and PCA analysis 
  
  
Although different metabolite patterns were observed by visual inspection of LC-MS 
chromatograms in the samples from different provinces, we attempted to analyze the results 
more holistically using  PCA  to  explore  the  relative  variability  in  the  samples  from 
different origins. Extracts were analyzed only in negative ion electrospray ionization HPLC- 
(CSI) MS mode. All the sixty samples were analyzed and no clear separation w a s  
achieved for both 2D and 3D (Figures 4.7 and 4.8) PCA plots. The samples d i d  n o t  
separate,  indicating that they are related in composition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: 2D score plot between selected PCs. The explained variables are shown in 
bracket
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Figure 4.8: 3-D PCA Score plot between the selected PCs. The explained variances 
are shown in brackets. 
 
4.4.3 MS data processing and PLS-DA analysis 
 
The 2D score plots (Figure 4.9) did not show a clear separation although the samples from the 
provinces showed some clustering. The 3D plot (Figure 4.10) showed that five distinct clusters are 
formed,  distributed  over  three  opposing  regions  on  PLS-DA  plots  corresponding  to  five 
different  provinces  researched.. L, G and KZN were placed on the left side of the vertical line, 
representing PC1, whereas M and NW samples were placed on the right.  Discrimination between 
samples from L, from G and KZN is also possible; with KZN samples on the lower left part of the 
score plots (Figure 4.11). Mpumalanga (M) and NW are in the same quadrant, i.e. related in 
composition but still distinct. The separation observed in PLS-DA can further be explained in terms of 
the identified compounds using loading plots. When the loading plots are performed, the unknown 
compounds with the masses, 381.19, 289.18, 171.01, 261.05, 453.11, and 418.14 are the most 
prominent compounds in the plot (Figure 4.10). 
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                Figure 4.9:  2-D PLS-DA Score plot between the selected PCs. The     
explained variances are shown in brackets. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
              Figure 4.10:  3-D PLS-DA Score plot between the selected PCs. The explained 
variances are shown in brackets. 
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 Figure 4.11: The loading plot for the PLS-DA. 
 
After unsupervised cluster analysis (Figure 4.7) and supervised PLS-DA analysis (Figure 4.9), fifteen 
metabolites (the total VIP value of the principal components of every metabolite was above 1.0) were 
obtained as differential metabolites (table 4.2).  All the metabolites annotated in table 4.2 were present in 
high concentrations in the samples from North West, Mpumalanga and KwaZulu-Natal respectively. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Important features identified by PLS-DA. The colored boxes on the 
right indicate the relative concentrations of   the corresponding metabolite in each 
group under study. 
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Table 4.2: Metabolites annotated from VIP scores 
 
 
  
 
 
4.5 Concluding remarks 
 
Metabolic profiling and metabolomic techniques are reliable and well-studied investigative tools. In this 
study, methanol extracts of S. birrea leaves from different provinces (L, KZN, G, NW and M) were 
compared and characterized based on multivariate statistical analysis of LC-MS data. Because of its great 
sensitivity, LC-MS detected mostly secondary metabolites.  Many of the metabolites could not be 
accurately annotated as further analysis is necessary. For a more detailed annotation of all metabolites, 
MS/MS will be carried out in which fragmentation of a parent ion mass will be made. The metabolites 
annotated in the VIP score were previously reported to have anti-diabetes potential, which supports the use 
and application of the technique. It was however important that the anti-diabetes potential of the samples 
be determined on samples from individual provinces in order to confirm the importance of these 
compounds in the samples and to determine the effect of the concentration differences of these 
metabolites. The next step in this study was to screen the samples for blood glucose uptake activity, to 
determine if the difference in compounds and the difference in concentration would affect the anti-diabetic 
potential of the samples from the five provinces. Overall LC-MS was sensitive enough to detect the less 
abundant secondary metabolites from S. birrea leaves which could not be easily detected by NMR. 
 
[M-H]- m/z Annotation
463.0531 Myricetin 3-0-α-L-rhamnopyranoside
441.0723 (-)-Epicatechin 3-0-galloyl ester
447.1466 Quercetin 3-0-α-L-rhamnopyranoside
231.0232 Unknown
209.0407 Unknown
285.0954 Unknown
210.0454 Unknown
565.1498 Unknown
423.0952 Unknown
489.291 Unknown
179.0649 Unknown
615.1344 Quercetin 3-0-β-D(6''-galloyl)galactopyranoside
426.1108 Unknown
439.101 Unknown
534.1929 Unknown
72 
 
 
 
 
 
4.6 LITERATURE CITED 
 
CAMACHO, D., DE LA FUENTE, A., & MENDES, P. (2005). The origin of correlations in 
metabolomics data. Metabolomics, ( 1),  pp. 53–63. 
 
CROCKFORD, D. J., HOLMES,  E., LINDON,  J. C., PLUMB,  R. S., ZIRAH, S., BRUCE, 
S. J., RAINVILLE,  P., STUMPF,  C. L., & NICHOLSON,  J. K. (2006). Statistical  
heterospectroscopy,  an approach  to the integrated  analysis  of NMR and UPLC-MS  
data sets: Application  in metabonomic toxicology studies. Analytical Chemistry, ( 78), 
pp.363–371. 
 
FORSHED, J., IDBORG, H., & JACOBSSON, S. P. (2007a). Evaluation of different 
techniques for data fusion of LC/MS and 1H-NMR.  Chemometrics  and  Intelligent  
Laboratory  Systems,  (85), pp.  102-109. 
 
FORSHED, J., STOLT, R., IDBORG,  H., & JACOBSSON,  S. P. (2007b). Enhanced  
multivariate analysis  by  correlation  scaling  and  fusion  of  LC/MS  and  H-1  NMR  
data.  Chemometrics   and  Intelligent Laboratory Systems, ( 85), pp.179–185. 
 
LE  GALL,  G.,  COLQUHOUN,  I. J., DAVIS,  A. L., COLLINS,  G. J.,  & VERHOEYEN,  
M. E. (2003). Metabolite profiling of tomato (Lycopersicon esculentum) using 1H 
NMR spectroscopy as a tool to detect potential  unintended  effects following  a genetic 
modification.  Journal of Agricultural and Food Chemistry, ( 51), pp.2447–2456. 
 
MOCO, S., BINO,R. J., VORST, O.,VERHOEVEN,H.A., DE GROOT, J., VAN BEEK, T. A., 
VERVOORT,  J., & DE VOS, R. C. H. (2006a). A liquid chromatography-mass  
spectrometry-based metabolome database for tomato. Plant Physiology, ( 141), pp.1205–
1218.  
 
MOCO, S., TSENG, L. H., SPRAUL, M., CHEN, Z., & VERVOORT, J. (2006b). Building-up a 
comprehensive  database of flavonoids based on nuclear magnetic resonance data. 
Chromatographia,9(10), pp.503– 508. 
 
 
73 
 
 
 
 
 
 
  
MOCO, S., BINO, R., DE VOS, R. C. H., & VERVOORT,  J. (2007a). Metabolomics  
technologies and metabolite identification.Trends in Analytical Chemistry, (26), pp. 855–
866 
 
MOCO, S., CAPANOGLU, E., TIKUNOV, Y., BINO, R. J., BOYACIOGLU, D., HALL, R. D., 
VERVOORT,  J.,  &  DE  VOS,  R.  C.  H.  (2007b).  Tissue  specialization  at  the  
metabolite  level  is percieved during thedevelopment of tomato fruit. Journal of 
Experimental Botany, (58), pp.4131–4146. 
 
MATTOO, A. K., SOBOLEV, A. P., NEELAM, A., GOYAL, R. K., HANDA, A. K., & 
SEGRE, A. L. (2006). Nuclear magnetic resonance spectroscopy-based  metabolite 
profiling of transgenic tomato fruit  engineered  to accumulate  spermidine  and spermine  
reveals  enhanced  anabolic  and  nitrogen– carbon interactions. Plant Physiology, 
10(1104), pp.106.08440 
 
MOUNET, F., LEMAIRE-CHAMLEY, M., MAUCOURT, M., CABASSON, C., GIRAUDEL, J. 
L., DEBORDE, C., LESSIRE, R., GALLUSCI, P., BERTRAND, A., GAUDILLERE, M., 
ROTHAN, C., ROLIN, D., & MOING, A. (2007). Quantitative metabolic profiles of 
tomato flesh and seeds during fruit development: Complementary analysis with ANN and 
PCA. Metabolomics, (3),pp. 273–288.  
 
SCHAUER, N., ZAMIR,  D., & FERNIE,  A. R. (2005).  Metabolic  profiling of leaves and 
fruit of wild  species  tomato:  A  survey  of  the  Solanum  lycopersicum  complex.  
Journal  of  Experimental Botany, ( 56), pp.297–307. 
 
STEUER,  R.  (2006).  On  the  analysis  and  interpretation   of  correlations   in  metabolomic   
data. Briefings in Bioinformatics, ( 7), pp.151–158.  
 
TIKUNOV, Y., LOMMEN,  A., DE VOS, R. C. H., VERHOEVEN,  H. A., BINO, R. J., 
HALL, R. D., & BOVY, A. G. (2005). A novel approach for nontargeted data analysis for 
metabolomics. Large- scale  profiling  of  tomato  fruit  volatiles.  Plant  Physiology,  
(139), pp. 1125–1137.  
74 
 
 
 
 
 
 
 
TRYGG, J., HOLMES, E., & LUNDSTEDT,  T. (2007). Chemometrics in metabonomics.  
Journal of Proteome Research, ( 6), pp.469–479. 
75 
 
 
 
 
 
5 
 
 
Assessment of the glucose uptake activity of 
aqueous Sclerocarya birrea leaves 
 
 
 
 
 
 
 
 
 
 
 
5.1 Abstract 
 
Sclerocarya birrea (S. birrea) is a well-known traditional plant. Its geographical origin can 
be determined by its biochemical composition. In this study the metabolic pattern in S. birrea 
from Limpopo, KwaZulu-Natal, North West, Gauteng and Mpumalanga was measured on 1H 
NMR, followed by multivariate data analysis. The samples clearly separated according to 
five groups, representing their places of origin. The separation was also observed between 
male and female samples. To investigate the anti-diabetes potential of S. birrea, the aqueous 
extracts from five different provinces were screened against C2C12 myocytes.  Since 
metabolomics revealed the difference between male and female samples, an investigation on the 
male and female samples was conducted to determine the differences between the samples. All the 
extracts were active in C2C12 myocytes. The male samples from Mpumalanga gave the best 
overall results with the activity higher than that of insulin, the positive control. This screening 
system increases the likelihood of identifying drug candidates using in-vitro anti-diabetic 
screening of crude plant extracts.  The highest activity in the male samples is believed to be 
encouraged by the highest intensity of (-)-epicatechin-3-galloyl ester, a secretagogue compound 
found in the male samples. The results of this experimental tissue culture study indicate that 
aqueous extract of S. birrea possesses hypoglycemic activity, and therefore confirms the 
suggested folkloric use of the plant in the management and/or control of adult-onset, type-II 
diabetes mellitus in some African communities. 
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5.2 Introduction 
 
 
Diabetes mellitus is a metabolic disorder characterized by a loss of glucose homeostasis with 
conflict of  carbohydrate,  fat  and  protein  metabolism  resulting  from  defects  in  insulin 
secretion, insulin action or both (WHO, 1999; Pietropopo, 2001; Defronzo, 2004). Without 
enough insulin, body tissues in particular, the liver, muscles and adipose tissues fail to take 
and utilize glucose from the blood circulation.   The stem bark of S. birrea has previously 
been found to possess anti-diabetes potential (Ojewole, 2008). The study by Ojewole 2008 
opened doors for more studies on other parts of S. birrea, especially the ones with no 
detrimental effect on the plant during harvesting. In the current study the in-vitro glucose uptake 
was assessed on the leaves of S. birrea. The use of in-vitro studies to evaluate the glucose 
uptake in cell lines following stimulation with insulin and other active compounds and plant 
extracts, is a direct and sensitive method of determining the glucose lowering effect of these 
agents (Van de Venter et al.., 2008).   It allows for rapid screening of compounds in terms of 
their efficacy and toxicity in an ethically acceptable manner (Van de Venter et al.., 2008).    
 
Other cell lines, not tested in this study include C3A and 3T3-L1 clonal mouse embryonic 
fibroblastic cells.  C3A cells are a clonal derivative of HepG2 cells that are used for a wide 
application of in- vitro screening due to strong contact inhibition of growth, high albumin 
production, and high production of alpha fetoprotein (AFP), oxygen dependent gluconeogenesis 
and the ability to grow in a glucose deficient medium (Kelly 1994; Iyer et al.., 2010). These 
characteristics contribute to these cells expressing a wide range of liver-specific functions.3T3-
L1 clonal mouse embryonic fibroblastic cells are chemically transformed into lipid- accumulating 
adipocytes. These cells are representative of adipose tissue, an insulin-sensitive tissue type 
involved in peripheral glucose clearance and maintenance of glucose homeostasis (Van de Venter 
et al., 2008). 
 
The C2C12 muscle cells are derived from mouse myoblasts. C2C12 cells differentiate rapidly to  
form  myotubules,   thereby  expressing  muscle  proteins  such  as  GLUT4,  the  insulin 
responsive glucose transporter. These cells have been used as in-vitro models to study myogenesis  
and  cell  differentiation,  glucose  metabolism  and  insulin  signaling  (Van  de Venter et al.., 
2008; Brunetti et al., 1989). In this study five S. birrea extracts were exposed to C2C12 muscle 
cells in order to assess the in-vitro glucose uptake of the extracts by these muscle cells. 
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5.3 Materials and methods 
 
 
5.3.1 Preparation of plant extracts for anti-diabetic screening 
 
Plant leaves from five provinces L, G, NW, M male (M) and female (F), and KZN were separated 
and air dried in a room with adequate ventilation. Dried plant leaves were ground to a course 
powder using a hammer mill and stored at an ambient temperature prior to extraction. For each 
extraction procedure 150g of powdered plant material was extracted with 1, 5 L purified water 
for 24hours.The aqueous extracts were concentrated by freeze- drying and stored at -20°C. 
 
5.3.2 In-vitro Cell Culture Models 
 
 
C2C12 in-vitro Glucose Uptake  Model. 
 
During culture C2C12 myocytes were exposed to the aqueous extracts (L, M (f), M (m), KZN, 
NW and G) prepared in Krebs-ringer bicarbonate HEPES buffer (KRBH) containing 8 mM 
glucose for one hour at concentrations ranging from 100, 10, 1, 0.1,   0.01 µg/mL. After the one 
hour incubation, glucose uptake in C2C12 cells was determined using pulse-labeling with  
[3H]-2-deoxy-D-glucose   (3H-2-DOG)  in  glucose-free  KRBH  buffer  containing  the 
extracts for fifteen minutes.  2-deoxy-D-glucose is a fierce competitor with D-glucose  for 
glucose transport across the cell membrane and can therefore be used to estimate the rate of D-
glucose  uptake.  Once  transported  into  the  cell,  labeled  2-deoxy-D-glucose  is 
phosphorylated by hexokinase to 2-deoxy-D-glucose-6-phosphate  but unlike D-glucose, due to  
a  missing  hydroxyl  group,  cannot  be  metabolized  further  and  remains  as  an  inert  
intracellular metabolite. Liquid scintillation counting was used to measure intracellular 3H-2-
DOG. Insulin (1µM) was included as a positive control and metformin (1µM) as a reference 
drug control. 
 
Activity was determined as fmol (3H-2-DOG)/mg (protein) and expressed below as 100% 
relative to the aqueous control. The extracts, insulin (1µM) a positive control and metformin 
(1µM) as a reference control are expressed as % relative to the aqueous control. 
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5.3.3 Data analysis 
 
Means and SEM are from three replicates in a single experiment. One way ANOVA was 
performed with a Dunnet’s post hoc test if p ≤ 0.05 that was deemed to be statistically significant. 
 
 5.3.4 Preparation of extracts for NMR spectroscopy 
Six samples used for in-vitro glucose uptake assays were used again for NMR spectroscopy. NMR 
analysis where done on a Varian 600 MHz spectrometer (CSIR) operating at a proton NMR 
frequency of 599.74 MHz where 50mg of the dried leaf material was dissolved in 750 µl 
Deuterium oxide and 750 µl potassium phosphate buffer in 0.1% TSP. The mixture was 
sonicated for 20 minutes and then centrifuged for  10  minutes  at  13  000  rpm,  room  
temperature,  and  600 µl  of  the supernatant were transferred to standard 5-mm NMR tubes. 
Gradient shimming was used to improve the magnetic field homogeneity prior to all 
acquisition. All spectra were Fourier- transformed, phase-corrected and baseline- corrected 
manually. 
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5.4 Results and discussions 
From all the 60 samples used for NMR, only six samples were used  for  glucose  uptake  assays  
due  to  the  high  cost  of  anti-diabetic  screening procedures. Figure 5.1 shows the glucose 
uptake in C2C12 myocytes. Since S. birrea has separate male and female trees, which might 
contain different chemical profiles, it was of great importance to determine the anti -diabetes 
potential of the male and female samples separately. From each province a representative sample 
consisting of both male and female was used. Exception was made for Mpumalanga samples; 
Mpumalanga samples showed to have anti-diabetes activity in the experiments carried out 
previously at the University of KZN (results unpublished).  The samples were labeled A-F, 
representing Limpopo, Mpumalanga (female), Mpumalanga (male), KwaZulu-Natal , North West  and 
Gauteng respectively  (Figure 5.1). 
 
Various glucose uptake assays exist, employing different methodologies (Soumyanath and 
Srijayanta, 2005; Zou et al., 2005). In the present study, glucose uptake was monitored in 
C2C12 cells, using insulin as a positive control. Aqueous extracts of S. birrea from the five 
provinces  (Limpopo,  Mpumalanga,  Gauteng,  KwaZulu-Natal  and  North West)  showed  activity,  
which  indicated  the  presence  of compound/s that possesses insulin mimetic properties.  The male 
extracts from Mpumalanga (Figure 5.1 c) caused a significantly (p<0.01) higher increase in 
glucose uptake in C2C12 cells in comparison to the positive control, insulin. The latter may 
implicate that this crude extract may be developed into a potent therapy in preventing and 
alleviating hypoglycemia. 
 
The male extract showed better results than the female extract which support the statement from 
Shackleton and co-workers with interviews in Namibia that “The medicinal power of the male tree is 
greater than that of the female tree” (as cited in Shackleton et al., 2002). At 100 µg/mL the activity was 
higher than insulin the positive control. The extract from KZN increased glucose uptake at 0.1µg/mL; 
however appears to be cytotoxic at 100 µg/mL as glucose uptake is reduced to ca. 64% of the control.  
 
The NW extract significantly improved glucose uptake at 1 µg/mL. The activity was comparable to that 
of insulin.  Similar activity  was  observed  for  extract  G  at  1  µg/mL however at 100 µg/mL glucose 
uptake was reduced to ca. 83% of the control. The extracts from L, NW and G demonstrated almost 
identical activity in the assay. This is in agreement with the LC-MS results that showed almost identical 
profiles and clustering of samples from L and NW (Figures 4.3 and 4.4). A table with glucose uptake 
data is shown in table 8.1 appendix. 
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Figure 5.1: Glucose uptake activity % in C2C12 myocytes exposed to aqueous 
7extracts of  Limpopo (Fig 5 A), Mpumalanga (Female) (Fig 5 B), Mpumalanga 
(Male) (Fig 5C), KwaZulu-Natal (Fig 5 D), North West (Fig 5E) and Gauteng (Fig 
5F). The percentage is expressed relative to the control at 100.
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In the study conducted at MRC in collaboration with UKZN ( Results unpublished), the 
assessment of cytotoxicity using the MTT assay showed no extract-induced cytotoxicity at 
any of the concentrations tested in the  C2C12 cells ( Figure 5.2), and the same cell lines 
and extracts where used in this study. Therefore, the extracts showed significant 
enhancement of glucose uptake in C2C12 myotubules without showing any form of 
toxicity. 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.  Percentage cell viability of C2C12 cells. 
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5.4.1 Metabolomic analysis of the male and female S. birrea aqueous 
extracts 
 
When the sixty samples extracted with methanol (in chapter 3), were extracted with water, the 
separation between the male and the female extracts was clear. The supervised OPLS-DA model 
for distinguishing male and female S. birrea samples from different provinces was established 
using six components and revealed R2X and Q2 values of 0.940 and 0.640 respectively. 
Although there is a slight overlap between the male and female samples, which may be a result of 
the metabolic variation between the two classes not related to gender, the scores still showed 
separation of compounds according to their genders (Figure 5.3).  The methanol extracts couldn’t 
separate based on genders (appendix 8.5). In the contribution plot (Figure 5.4) the aliphatic and the 
sugar regions were found to be important in the female samples as opposed to the males. The male 
samples were found to be   rich in aromatic metabolites (negative bars of Figure 5.4), which support 
the greater anti-diabetes activity presented by the male samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: OPLS-DA score plots for female and female S. birrea aqueous extracts. The 
green scores represent the females while the blue represent the male extracts. 
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Figure 5.4: Contribution plots for female S. birrea aqueous extracts. The bars/ peaks 
upwards represent metabolites important in clustering of the female samples.  
 
 
A significant difference in activity was observed between the male and female samples of 
Mpumalanga indicating a difference in chemical profile between the male and female samples. 
To investigate which metabolites have contributed to the activity in all the six samples, 1H NMR 
was carried out on the six aqueous extracts used for glucose uptake assays (Figure 5.5). Visual 
inspection of the six extracts, confirmed them to be rather similar.  Compounds such as Gallic 
acid were also found in all the samples.  In the study by Gopalakrishnapillai et al (2010), 
induction of glucose uptake activity with Gallic acid was performed in 3T3-Li cells, and their 
results showed that only 10 micromolars of Gallic acid caused 90% increase in glucose uptake 
activity compared to untreated cells. In the present study the presence of Gallic acid will then 
also contributes to the anti-diabetes activity of the samples.   
 
The male samples from Mpumalanga province presented a maximum activity without showing 
any forms of toxicity.  The female samples from the same province showed some signs of 
toxicity at a concentration of 10µg/ml (Figure 5.1b), in that the activity decreased. For further 
understanding on why the samples from Mpumalanga had the different activities, the NMR 
spectra of the two samples (males and females) were compared.  Visual inspection showed that 
the two spectra are rather similar (Figure 5.6), and they also showed generally equal intensities 
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in the levels of metabolites. Nevertheless, the difference in the levels of (-)-Epicathechin 3-0-
galloyl ester was observed (Figure 5.7). This metabolite was previously found to have 
secretagogue activity in the study by Galvez et al., 1991. At this point in this study, it can be 
appreciated that the higher concentrations of this metabolite in the male samples from 
Mpumalanga will also contribute to the greater activity presented in this extract. The possibility 
of other compounds that might become more toxic at high concentrations should be considered, 
especially in commercial development of the extracts and will warrant future studies. 
  
 
Figure 5.5: Spectra of the queues Sclerocarya birrea leaves extracts used for blood 
glucose assay. 
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Figure: 5.6: NMR spectrum of the male and female samples from Mpumalanga. The 
blue spectrum represents the female samples and the red represent the male samples 
showing the similarities between the samples. 
 
 
Figure 5.7: NMR spectrum of the male and female sample from Mpumalanga. The 
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blue spectrum represents the female and the red represent the males. The difference 
in the concentration of (-) - epicatechin 3-0-galloyl ester is indicated at 6.90 ppm. 
 
5.5 Concluding remarks 
  
In this chapter it was clearly illustrated that S. birrea causes improvement in blood glucose uptake in 
C2C12 muscle cells, and this can be accounted for, by the blood glucose reduction through glucose 
utilization by muscle tissue. The effect (s) therefore of S. birrea on the blood glucose uptake may be 
useful for treating patients with insulin insufficiency or insulin resistance, however the nature and 
mechanism of these effects needs to be investigated.   It is important to note that from the results it is 
confirmed that the leaves of S. birrea are effective in uptake of glucose from blood.  Furthermore the 
results also indicate that the male S. birrea leaves are more effective as compared to the female samples. 
The mechanism of action of the male extract in lowering blood glucose is not known; therefore isolation 
of compounds from the active extracts will be ideal to further understand the differences in activities 
presented by the extracts from different provinces. The presence of (-)-Epicathechin 3-0-galloyl ester 
in higher concentrations in the male sample might be a contributing factor in the increased activity of 
the male sample. The increased concentration in combination with other anti-diabetic compounds such 
as Gallic acid explains the positive results obtained in the assay.  
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6 
General discussion
 
 
 
 
 
 
 
In this study, methanol extracts of S. birrea from different provinces were compared and 
characterized based on mult ivariate statistical analysis of 1H NMR –based metabolomics data. 
Visual inspection of the spectra from five provinces looked similar confirming the similarities 
within the S. birrea samples from different provinces. A number of the primary metabolites 
(sugars) and few secondary metabolites (phenolics) were identified. Although there were 
similarities, the differences were also clear, which can allow the use of some of the metabolites as 
biomarkers.  Sclerocarya birrea from different provinces exhibited significant differences in their 
metabolite profiles with closer investigation. Intense signals in the sugar region mostly in the 
samples from Gauteng were observed, indicating the presence of glycosylated metabolites and free 
sugars.  
 
The OPLS-DA scores revealed three different groups. The first group represented samples from 
Gauteng, the second group represented samples from KwaZulu-Natal and the third group 
represented the samples from Limpopo, North West and Mpumalanga.  The third group which 
contained samples from three different provinces confirmed that these provinces had more 
similarities than the samples from other provinces. When the contribution plots were performed, 
indeed Gauteng presented the sugars as important metabolites in this province.  
 
Liquid Chromatography-Mass Spectroscopy confirmed both the similarities and the differences 
between the samples from different provinces. The supervised and unsupervised scores showed 
that the samples were from different places, by separating them into five groups representing the 
place of origin for each. The metabolites in the VIP scores analysis were mostly annotated with 
Myricetin 3-0-α-L-rhamnopyranoside, (-)-Epicatechin 3-0-galloyl ester, Quercetin 3-0-α-L-
rhamnopyranoside and Quercetin 3-0-β-D(6''-galloyl)galactopyranoside important compounds in 
samples from North West, Mpumalanga and KwaZulu-Natal.  
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The application of analysis of untargeted metabolomics data, obtained by LC-MS and `1H NMR 
based profiling of exactly the same biological material, appears to be a powerful strategy in 
discovering and linking metabolite information which can be used in biomarker discovery and 
annotation. From the metabolites annotated, some metabolites observed in NMR were not identified 
in LC-MS and vice versa; this was due to the differences in the degree of sensitivities between the two 
techniques. Nevertheless, the two techniques still complement each other in that it was also able to 
detect the common metabolite at 191 m/z (Myristicin or ‘1 Hydroxychavicol acetate ) as well as 
myricetin 463 m/z, quercetin 447m/z  and epicatechin  glycosides 441m/z. We compared the 
performance of OPLS-DA and PLS-DA from 1H NMR and LC-MS spectra respectively, to better 
evaluate the classification potential of both technologies.   When compared to the OPLS-DA of 
NMR data (Figure 3.6), it is apparent that the LC-MS results were in general agreement in both 
plots, G and KZN samples clustered separately from the other samples.  
 
The similarities between both plots are remarkable given to the observed divergence in metabolites 
detected. Therefore, it can be proposed that metabolic differences, which separate S. birrea leaves 
from five provinces belongs to both primary (mostly detected by NMR) and secondary (mostly 
detected by LC-MS) metabolism.  It might also indicate that there are specific metabolic pathways 
that are responsible for the chemical differences observed for both primary and secondary 
metabolites resulting in a similar clustering pattern for the LC-MS and NMR analysis. An attempt 
to identify more metabolites in the samples from five provinces will be done as part of the next stage 
in this study, for better understanding the similarities and differences between the samples. This shall 
be done using metabolomics techniques in which the obtained molecular mass from MS will 
be splitted; a technique known as MS-MS fragmentation. Having the similarities and the 
differences confirmed by LC-MS and 1H NMR, the in-vitro glucose uptake was done on samples 
from individual provinces. The activity for each   province was different, supporting the 
metabolomics analysis of the samples from five provinces. With regard to Mpumalanga samples, 
male and female samples in this study were screened separately.   The resulting blood glucose 
uptake assays confirmed the statement by Shackleton et al., 2002 which reported that male S. 
birrea plants have stronger medicinal values than females. Previous studies showed that aqueous 
and methanol  extracts  of the  stem  bark  and  roots of S. birrea  were  found  to enhance 
glucose utilization in cheng liver, C2C12 and 3T3-L1 cells (Van de Venter et al., 2008).   The 
glucose lowering effect of S. birrea using the in-vitro model is known and also supports the 
C2C12 results of the present study in which the cells were treated with aqueous leaf extracts of 
S. birrea (Gondwe et al., 2008; Makom et al., 2010; Ojewole, 2003; Dimo et al., 2007). Aqueous 
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stem bark extracts have been reported to lower blood glucose levels in diabetic rats (Ojewole, 2004; 
Ojewole 2003). A methanol/methylene chloride extract (150 and 300 mg/kg) has been found to 
cause a reduction in blood glucose levels and increase plasma insulin levels in diabetic rats 
(Dimo et al., 2007). 
 
A similar  hypoglycemic  effect with increased plasma insulin was reported in diabetic rats 
treated  with  300µg/ml  aqueous  stem  bark  extract  (Makom  et  al.,  2010).  Contradicting 
findings were reported in diabetic rats treated with ethanol stem bark extract (60,120 and 
240mg/kg),   in which a reduction   in blood glucose   levels without   significantly   affecting 
pancreatic insulin secretion was observed (Gondwe et al., 2008). These reports suggest that the 
plant extracts exerts their hypoglycemic effect independently of insulin, which supports the 
findings of the present study.  
 
In the study by Gopalakrishnapillai et al (2010), induction of glucose uptake activity with gallic 
acid was performed in 3T3-Li cells, and their results showed that only 10 micromolars of gallic 
acid caused 90% increase in glucose uptake activity compared to untreated cells. On cellular and 
molecular levels, kaempferol improves glycolysis, glucose uptake, glycogen synthesis, AMPK 
activity, and Glut4 expression in skeletal muscle, and dietary supplementation of kaempferol 
significantly ameliorated hyperglycemia and preserved functional islet mass in old adult obese 
diabetic mice (Alkhalidy et al., 2015). The presence of this metabolite in our extracts may explain 
the ability of the extracts to take up glucose and therefore the anti-diabetic potential of S. birrea 
leaves. It is evident that not only one metabolite in S. birrea leaves possess hypoglycemic potential, 
therefore as part of the activities in this ongoing project, an attempt to identify more metabolites 
using metabolomics techniques will be made. This shall be followed by fractionation of active 
compounds using chromatography, with the aim to isolate metabolite/s with anti-diabetes potential, 
and if possible identify the most effective compound. The activity presented by the male samples 
from Mpumalanga, suggests that (-)-Epicatechin 3-0-galloyl ester, contribute significantly to the 
activity expressed by these samples, since it was present in higher concentrations as compared to 
the females. According to literature epicatechins displays antidiabetic activities and is one of the 
most active antioxidant constituents (Berregi et al., 2003). Cho et al. (2006) found that catechins 
enhanced the expression and secretion of adiponectin, an adipocyte-specific secretory hormone that 
can increase insulin sensitivity and promote adipocyte differentiation. They also found that catechin 
treatment increased insulin-dependent glucose uptake in differentiated adipocytes and augmented 
the expression of adipogenic marker genes. In search of the molecular mechanism responsible for 
the inducible effect of (-)catechin on adiponectin expression they found that catechin suppressed 
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the expression of Kruppel-like factor 7 protein. This protein inhibited the expression of adiponectin 
and other adipogenesis related genes that play an important role in the pathogenesis of type 2 
diabetes. Zaid et al. (2002) found that treatment with epicatechin (1mM) resulted in a significant 
increase in the activity of erythrocyte Ca
++
-ATPase in both normal and type 2 diabetic patiences. 
According to Jalil et al. (2009) the intake for 4 weeks of a cocoa extract supplemented with 
polyphenols (2.17 mg epicatechin, 1.52 mg catechin, 0.25 mg dimmer and 0.13 mg trimer g-1 
cocoa extract) and methylxanthines (3.55 mg caffeine and 2.22 mg theobromine g-1 cocoa extract) 
significantly (P, 0.05) reduced the plasma total cholesterol, triglycerides and low-density 
lipoprotein cholesterol of obese-diabetic rats compared to non-supplemented animals. A study done 
by Kobayashi et al. (2000) using a rat everted sac showed that tea polyphenols consisting mainly of 
catechins, epicatechin gallate, epigallocatechin and epigallocatechin gallate inhibited sodium-
dependent glucose transporters. This indicated that tea polyphenols interacts with sodium-
dependent glucose transporters, possibly playing a role in controlling dietary glucose uptake in the 
intestinal tract.  
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7 Conclusion 
 
 
 
Despite the widespread medicinal use of S. birrea, the levels of most phytocontituents in leaf 
extracts are not all standardized and several compounds responsible for the pharmacological 
properties are not yet fully elucidated. An unbiased multiplex approach combining NMR and 
MS techniques was adopted to reveal compositional differences in primary and secondary 
metabolites among S. birrea f rom different geographical regions using multivariate data 
analysis.  Interesting and meaningful differences between the various samples and detection 
method were identified. 
 
To the best of our knowledge, this study provides the first approach to reveal metabolite 
compositional differences among S. birrea leaves from different provinces and between male and 
female trees. LC-MS appears to be a suitable   method to determine   species relationships,   
whereas NMR is ideal for quantification of metabolites and it is easy to perform. When 
compared to OPLS-DA plots of NMR  data  (Figure  3.6)  it  is  apparent  that  the  LC-MS  PLS-
DA  results  were  in  general agreement. In both OPLS-DA and PLS-DA plots, G and KZN 
samples were clustered separately from the other samples. NMR mostly detected the primary 
metabolites while LC-MS detected secondary metabolites. 
 
Very few non-flavonoid phenolic compounds were detected, but we could not detect any of the 
complex flavonoid phenolic compounds.  This is probably due to their complexity, and they were 
probably unable to dissolve in methanol at a very short time used for the extraction. Although 
many metabolites still need to be identified, the metabolites annotated in this study, provide support 
for the anti-diabetic activity presented by the samples. The six extracts will be further screened for 
glucose uptake activity in-vitro with other cell line types ( 3T3-Li, and C3A) and in-vivo. The 
samples will also be subjected to chromatographic fractionation, and  fractions which show the best 
biological activity in the bioassay will be selected for further fractionation and subsequent 
identification of the compounds.  
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   Figure 8.1: OPLS-DA plots for 60 S. birrea samples with the exclusion of the 
aromatic region (6.5-8ppm) 
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    Figure 8.2: OPLS-DA plots for 60 S. birrea samples with the exclusion of the 
aliphatics  ( 1-2.5ppm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Figure 8.3 Important features identified by two-way ANOVA 
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  Figure 8.4: OPLS-DA plots for sixty aqueous S .birrea samples.
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Figure 8.5: OPLS-DA   of the male and female plots  of methanol S. birrea samples  
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Table 8.1: C2C12 glucose uptake data. 
 
 
Glucose Metformin Insulin
1µM 1µM 0.01 0.1 1 10 100 0.01 0.1 1 10 100 0.01 0.1 1 10 100 0.01 0.1 1 10 100 0.01 0.1 1 10 100 0.01 0.1 1 10 100
Activity % 100 120 140 90 110 140 90 90 100 110 120 110 100 90 100 110 100 98 100 110 110 120 190 96 97 100 95 96 110 120 110 100 60
KwaZulu-NatalMpumalanga femaleLimpopo Gauteng North West Mpumalanga male
